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Introduction: Mental health is a public health concern on university campuses. 
However, little is understood about the etiology of mental health in this population.  
 
Purposes: To measure the association between the non-medical use of sedative and 
sleeping pills in the past three months and moderate-extremely severe symptoms of 
depression, anxiety, and stress in the past week, in undergraduate students at the 
University of Ontario Institutes of Technology (UOIT). 
 
Methods: Cross-sectional study of undergraduate students enrolled in the faculty of 
health sciences and faculty of education at UOIT in the Fall semester of 2017.  
 
Findings: Few students reported lifetime (7.8%) and past three month (3.7%) non-
medical sedative and sleeping pill use. More students reported moderate-extremely 
severe symptoms of depression (30.3%), anxiety (47.3%), and stress (25.5%). I found no 
association between non-medical sedative and sleeping pill use and moderate-extremely 
severe symptoms of anxiety, stress, and depression. 
 
Discussion: Despite no association between non-medical sedative and sleeping pills use 
and symptoms of anxiety, stress, and depression, students must be educated about the 
potential negative health impacts of non-medical sedative and sleeping pill use. 
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1.1 MENTAL HEALTH 
1.1.1 Mental Health in Young Canadian Adults 
 Recent surveys of Canadians suggest that 10% of the population meets the criteria 
for a mental health or substance use disorder in the past year
1
. Although mental health 
impacts all Canadians, the risk may be higher for youth between the ages of 15 to 24 
years
1
. This is significant because poor mental health is associated with suicide, which is 
one of the leading causes of death in adults under the age of 35 years
2
. Certainly, in my 
own experience as a mental health worker, I have received a steady stream of referrals for 
people under 24 years old. Typical complaints range from issues with relationships, 
anxiety, and stress, to self-harm, suicide attempts, and substance use. Individuals between 
the ages of 15 to 24 years may be more vulnerable to developing mental health problems 
because of the critical developmental periods and key life changes occurring during this 
time, and transitions from adolescent to adult services
3
. One key life change that may 
play a role in mental health is the transition to post-secondary school education. This may 
be because students away to school for the first time may become disconnected from their 
support networks and have difficulty adapting to a new environment and navigating 
difficult social and academic challenges.  
  
1.1.2 Prevalence of Depression, Anxiety, and Stress in University Students 
Symptoms of depression, anxiety, and stress are common in undergraduate university 
students.  According to the 2016 National College Health Assessment, in the past 12 
months 64.45% of Canadian university students reported experiencing “overwhelming 
anxiety”; 44.4% reported feeling “so depressed it was difficult to function”; and 42.2% 
reported stress had an impacted their academic performance
4
. This represents an increase 
from 2013, where in the past year 56.5% of students in Canada reported “overwhelming 
anxiety”; 37.5% reported feeling “so depressed it was difficult to function”; and 38.6% 
reported stress had an impacted their academic performance
5
. These statistics, although 
striking, do not provide measures of diagnosis; rather, they refer to the prevalence of self-
reported mental health symptoms. Studies conducted using psychometrically sound scales 




students report anxiety in the last 4 weeks
6,7
, and that between 13% and 17.9% report 
depression in the last 2 weeks
6,7
. Another cross-sectional study found that 14% of 




Mental health problems, such as depression and stress, can have a significant 
negative impact on student experiences, performance, and behaviour. Arria et al.
8
 found 
that depression in the first two years of university is associated with early dropout from 
school. Stallman
9
 found that higher psychological distress was associated with lower 
GPA in university students. Moreover, mental health problems are positively associated 
with cyber addiction, eating disorders, substance use (smoking, alcohol and drugs), self-
harm, and increased risk of suicide
10-15
. 
The etiology of anxiety, depression, and stress in university students is poorly 
understood but the non-medical use of prescription medications is hypothesized to be a 
risk factor
12,16-18
. The non-medical use of medications may be associated with poor 
mental health through motivations for use related to poor sleep quality, coping with 
anxiety or stress, and getting high
16-18
. For example, a student struggling with a lack of 
sleep may misuse a sedative to help them sleep. Or another student may misuse pain 
medication for recreational purposes. The association between mental health and drug use 




The current evidence about the use of prescription medication and its misuse 
highlight the need to study this association in university students. Previous studies 
suggest that the proportion of American college students who reported misuse of any 
medication in the past year remained stable between 2003-2013 (13.6% in 2003; 13.1% 
in 2013)
19
. One interesting finding about patterns of use over time is that the misuse of 
sedative medications in the past year have also remained constant (2.9% in 2003; 3% in 
2013)
19
. Drawing on my own experiences as a mental health worker, it was common to 
see individuals misusing sedative medications; more so than other types of medications. 
In addition, compared to other types of medications, there appeared to be a more casual 




extra sedatives to help cope with breakthrough symptoms, and sharing sedatives with 
others. 
 
1.2 SEDATIVE USE 
1.2.1 General Population 
Sedative medications are one of the most widely prescribed medications in 
Canada
20
. Common sedatives include benzodiazepines, barbiturates, and non-
benzodiazepine drugs (z-drugs), which are typically prescribed for anxiety or sleep 
difficulties. In Canada, 10% of the general population report current use of sedative 
medications
19
. Studies in the United States have reported significant increases in doctor 
visits involving benzodiazepine prescriptions since the early 2000s
21,22
. For example, one 
study found that the number of doctor visits that resulted in a benzodiazepine prescription 
increased from 2.6% in 1993 to 4.4% in 2010
21
. This is important because those who are 
prescribed sedatives may be more likely to use them for non-medical reasons, for reasons 
other than the prescription, and use other medications that are not prescribed to them
23
. 
In 2015, 3% of the Canadian
 
general population reported having used sedatives 
for non-medical reasons
24
. Research conducted in other countries provides similar results.  
In the United States, 2.3% of the general population report the non-medical use of 
prescription sedatives in the past year
25
 and in Switzerland 2.9% and 2.6% of the 
population reported use of sleeping pills and anxiolytics respectively in past year
26
. 
One of the main concerns with sedative use is its potential negative impact on 
health. A cohort study of in 3550 individuals from the general population in Sweden 
found that the 20 year mortality rate was 63.3% in men and 46.2% in women who 
reported regular sleeping medication use compared to 20.9% and 14.7% for men and 
women who did not report regular use of sleeping medication
27
. The authors concluded 
that regular hypnotic use significantly increased all-cause mortality and that regular use 
was a risk factor for suicide
27
. Another concern is overdose. Although overdosing on 
sedative medications alone can be difficult
28,29
, the risk of overdose increases 
significantly when mixed with other substances
28,30
. In the United States, benzodiazepine 






to hospital, and death
32
. Use of sedatives is also associated with risky sexual behaviours, 




1.2.2 University Students 
In Canada, 2.2% of post-secondary students reported using a sedative medication 
that was not prescribed to them in the past 12 months
4
 and 3% of high school students 
report non-medical use of sedatives in the past year
36
.  These results are consistent US 
statistics where between 2.3% and 3% of students reported using sleeping and anxiety 
medications without a prescription in the past year
18
.  McCabe et al.
19
 also reported that 
the lifetime use of sleeping and anxiety medication use was 4.8% and 5.4% respectively. 
Other studies suggest that lifetime prevalence of sedative use is higher, with 12.2% and 
10.1% of undergraduate students in the US reporting lifetime use of tranquilizer and 
sleeping medications, respectively
37,38
.   
 
1.3 REVIEW OF THE LITERATURE  
1.3.1 Association between Sedatives and Mental Health in University Students 
Previous research suggests that mental health problems and sedative use are 
prevalent in university students. However, few studies have investigated whether they are 
associated. Therefore, I reviewed the literature to synthesize evidence on the association 
between sedative use and depression, anxiety, or stress in university and college students. 
 
1.3.2 Methods 
1.3.2.1 Eligibility criteria 
Eligible studies investigated nonmedical use of sedative medications 
(benzodiazepines, barbiturates, and non-benzodiazepine drugs) in undergraduate and 
college students. These medications include broad categories of medications such as 
anxiolytics and hypnotics as well as specific medication classes like benzodiazepine. 
These medications are typically prescribed for sleep or anxiety
20
. Non-medical use of 






1.3.2.2 Study characteristics 
I considered studies that were published in peer-reviewed journals between 
January 2007 and January 2018.  The search terms for my review were adapted from a 
larger review on mental health and substance use conducted by the UOIT Mental Health 
and Wellness Study team.  These included: human subjects, substance use, non-medical 
use of prescription medication, clonazepam, benzodiazepines, sleeping pills, Ativan, 
university students, undergraduate students, mental health, anxiety, depression, stress 
(Appendix A).  Eligible designs included cohort, case-control, cross-sectional studies and 
systematic reviews. Systematic reviews were searched manually for additional 
references. 
 
1.3.2.3 Information sources 
I searched the literature using PubMED and PSYCInfo.  Search terms were 
entered into PSYCInfo on February 21, 2017 and the search was updated on January 7
th
, 
2018. Search terms were entered into PubMED on February 26
th
, 2017, and updated on 
January 5
th
, 2018 (Appendix A). 
 
1.3.2.4 Outcomes 
Relevant outcomes for my literature review included depression, anxiety, or 
stress. Studies that used self-report or diagnoses were eligible for review. Studies that 
investigated serious mental illness (ex. Schizophrenia, bipolar disorders, etc.) were 
excluded because these were not the focus of the study.  
 
1.3.2.5 Study selection 
Article titles and abstracts were downloaded in EndNote. I used a two-phase 
screening methodology to identify relevant articles.  In phase 1, I screened each article’s 
title and abstract for eligibility using the criteria described above. Articles that were 
possibly relevant (not enough detail was provided to determine eligibility in the title and 
abstract) were further reviewed in phase 2. In phase 2, the full text of articles was 







1.3.3.1 Study selection 
The search yielded 2684 articles. After phase 1 (title and abstract screening), sixty 
of the 2684 articles were selected for additional screening (phase 2). Articles were 
excluded if the study population was not undergraduate university or college students. 
Therefore, studies of medical, graduate, or high school students were not included in the 
review. I also excluded studies that explored sedative use in clinical or senior 
populations, and clinical investigations of physiological effects of these medications. The 
focus of my literature review was undergraduate students; thus any studies not directly 
related to undergraduate students, sedatives, and mental health, were excluded. After 
phase 2 screening was completed, eight articles were selected that met the search criteria 
(Appendix B). Five of the eight articles investigated the non-medical use of prescription 
medication and mental health in university students
38-42
. These studies included sedatives 
in their investigation of prescription medications, but do no separate sedatives from other 
medications in much of the analysis. They were kept for review because the report 
prevalence of sedative use and offer some insight into the potential association between 
sedative use and mental health. The remaining three studies focused on the non-medical 




1.3.3.2 Study characteristics 
All eight studies were cross-sectional (Table 1 and Table 2). Three studies defined 
non-medical sedative use as “medications that were not prescribed to you”
12,38,44
. Two 
studies defined non-medical use as “medications that were not prescribed to you” and 
“off label use”
39,42
. The remaining three studies used other definitions (use for coping and 




Three studies used psychometric assessments to determine mental health 
status
38,39,41
, one asked about self-reported experiences with symptoms of mental health
12
, 




and mental health by asking about reasons for substance use (i.e. use sedatives to cope 
with mental health issues)
40,42-44






Table 1. Studies that reported on the association between non-medical use of prescription medications and mental health disorders in 




Study Sample and 
Sample Size  
Substances Used 


















sedatives; use in the 
past year 




asking if they 




1-year prevalence of sedative use: 1.8%  
1-year prevalence of tranquilizer use: 2.3%  
Association between the non-medical use of prescription 
medications and lifetime diagnosis of depression: 
OR=2.67; 95% CI [1.74-4.11]  














asking if they 
have ever used 
and how often 
Stress Lifetime use of sedative medications: 5.8% 







275 first and second 
year students 













Stress Past 6 month prevalence of anxiolytics: 10.6%  
Past 6 month prevalence of sleeping pills: 7% 
Association between the non-medical use of prescription 









students enrolled in 
psychology courses. 
18-25 years old.  
Anxiolytics and 
sleeping medications; 
lifetime use past 3 
month use 
Not prescribed Question 
asking if they 
have ever used 
Health anxiety 10.1% reported using anxiolytics and 4.4% sleeping 
medications  
Association between the non-medical use of prescription 







students from a 








asking if they 






Lifetime prevalence of sedative use: 21% 
Lifetime prevalence of tranquilizer use: 23%  
Students reported using medications to deal with 
symptoms of stress and anxiety* 








Study Sample and 
Sample Size  
Substances Used 













22783 students from 
several universities 
from all over the US. 





Not prescribed Question 
asking if they 
have ever used 
Depression Association between sedative use and feelings of 
depression: OR=1.36; 95% CI [1.11-1.66]  
Stronger association between sedative use and depression 






students from a 
single school in the 
US. 
Benzodiazepines; 





asking if they 
have ever used 
Stress Lifetime benzodiazepine misuse: 3.3%   
26.7% reporting using to relax 
6.7% reported using to deal with stress* 
Paredes, et 
al.,  (2008) 
(Ecuador)  
181 nursing students. Benzodiazepines; 
lifetime, past year, 
current 
Not prescribed Question 
asking if they 






Current use of benzodiazepine without a prescription: 
3.9%  
43.5% reported use due to stress  
36.7% reported use due to anxiety  
38.5% reported use due to depression* 






Studies in Table 1 report lifetime, past year, or past 6 month prevalence of non-
medical sedative medications. These studies do not report any specific associations 
between sedatives and mental health, but they do report a positive association between 
non-medical prescription medication use and mental health (depression, stress, and health 
anxiety). Studies in Table 2 report lifetime or current prevalence of sedative use. These 
studies do look at sedatives independently of other medications and substances. One 
study found a positive association between sedative use and feelings of depression, while 
the rest of the studies reported on the number of students who used sedatives as a means 
to cope with a mental health issue.  
 
1.3.4 Study Results 
Overall, the studies included in my literature review support the hypothesis that 
non-medical use of prescription medications, specifically sedatives, are associated with 
prevalent mental health problems in students (Table 1 and 2). Although Studies in Table 
1 provide some insight they do not examine the association between sedatives and mental 
health. As a result they will be excluded from any further examination into the 
association between sedatives and mental health.  
 
1.3.4.1 Association between Sedatives and Depression 
One study found that students reporting sedative use were more likely to report 
feelings of depression (OR=1.36; 95% CI [1.11-1.66])
12
. When stratified by gender, the 
association was only present in females. Paredes et al.
44
 also found that of those reporting 
sedative use, 38.5% reported use as a means to cope with depression. 
 
1.3.4.2 Association between Sedatives and Anxiety 
One study commented on anxiety, reporting that in those who use sedatives non-




1.3.4.3 Association between Sedatives and Stress 
Finally, sedative medication misuse was frequently reported by university 
students as a mean to cope with stress.  Stone et al.
43




sedative use, 6.7% reported use as a means to cope with stress. Whereas Paredes et al.
44
 
found that 43.5% reported sedative use due to stress. 
 
1.3.5 Methodological Challenges with Studying Mental Health and Sedative Use in 
University Students 
Previous studies examining student mental health and prescription sedative use 
have limitations. Low response rate in studies involving university students is common 
and may have led to selection bias
4,6,40,45,46
. Another limitation is measurement bias 
related to the assessment of mental health. In some studies, mental health was measured 
as symptoms
12,45,46





.  Measurement bias in these studies may have occurred because 
the validity and reliability of measurements were poor or not established. The 
measurement of medication use has limitations as well. Studies commonly combined 
sedative medication with other prescription medications, such as opioids and stimulants 
(Table 1). This does not allow for sedative use to be reported separately of other types of 
substances. This is important because different medications may be used non-medically 
for different reasons
39
. There were also inconsistencies in the definition, classification 
and labelling of sedative type medications. For example, McCabe et al.
19
 lists sedatives as 
anxiolytics, while Holloway et al.
42
 lists sedatives as something separate from 





, and others still only assessed one type of sedative medications, 
such as benzodiazepines
43,44
. These measurement differences make comparison between 
studies difficult and can result in the underestimation of the use of these types of 
medications.   
 
1.3.6. Conclusion 
The current research on the non-medical use of prescription medications suggests 
that prescription medications, as a whole, have an impact on student mental health. 
Looking at sedative medications separately, this pattern appears to be similar. However, 
there are inconsistencies in how sedatives and mental health are defined and measured. 




results. The non-medical use of prescription sedatives and its association to student 
mental health is important to explore and more thorough investigation is needed.  
 
1.4 KNOWLEDGE and METHODOLOGICAL GAPS 
From an epidemiological perspective, little is known about non-medical use of 
prescription sedatives and its association with depression, anxiety, and stress in Canadian 
university students. Although research has been conducted in other countries, differences 
exist in the medical systems and prescription patterns, justifying the need to explore this 
association in Canadian students
25,26
.  Furthermore, previous studies used inconsistent 
definitions and measurement methods to collect data on and mental health
12,37,40,42-44
. 
Therefore, there is a need for a study that uses standardized, valid and reliable measures 
of sedative use and mental health (symptoms of depression, anxiety, and stress). 
Moreover, there are concerns about selection bias in previous studies
12,43,44
. Future 
research must adopt recruitment strategies that will maximize participation and reduce 
the potential for selection bias. 
 
1.5 SUMMARY 
Sedatives are central nervous system depressants, commonly prescribed for sleep 
and anxiety issues
20
. Previous research into the non-medical use of sedatives in the 
general population, as well as university students, suggests that a proportion of 
individuals use them for non-medical purposes
4,19,36
. But is the non-medical use of 
sedatives associated with mental health in university students? Anecdotally, my own 
experiences have suggested a link to mental health, as well as a casual attitude towards 
the non-medical use of sedatives. My review of the literature found only a few studies 
that have attempted to answer that question. These studies suggest that non-medical 
sedative use is more common in those reporting depression
11
, and that it is often used to 
cope with anxiety and stress
43,44
. However, there are concerns over methodological 
limitations with these studies, and no research has been conducted in Canada. Therefore, 
it is important to conduct rigorous research in this area because sedative use is associated 
with poor health outcomes (including the risk of overdose, risky sexual behaviours, 







1.6 THESIS OBJECTIVES 
The general objective of my thesis is to describe the use of non-medical use of 
prescription sedative and sleeping pills and measure the association between non-medical 
use of prescription sedative and sleeping pills and symptoms of depression, anxiety, and 
stress in undergraduate students in the faculty of health sciences and the faculty of 
education at the University of Ontario Institute of Technology (UOIT). 
 
1.6.1 Specific Objectives: 
1. To determine the lifetime and three-month period prevalence of non-medical 
sedative and sleeping pill use in undergraduate students in the faculty of health 
sciences and the faculty of education at UOIT. 
2. To determine the one-week period prevalence and symptoms of depression, 
anxiety, and stress in in undergraduate students in the faculty of health sciences 
and the faculty of education at UOIT. 
3. To determine whether non-medical sedative and sleeping pill use in the past three 
months is associated with symptoms of depression, anxiety, and stress in 
undergraduate students enrolled in the faculty of health sciences and the faculty of 
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We aimed to test the feasibility of conducting a cross-sectional survey of mental health 
and associated lifestyle factors in undergraduate students. Our online survey included 
validated instruments to measure depression, anxiety and stress symptoms and modifiable 
lifestyle factors. We requested feedback about the length, clarity, and content of the 
survey. Participants included 137 students enrolled in the Faculty of Health Sciences at 
the University of Ontario Institute of Technology in March, 2017. The participation rate 
was 80%. The average time of completion was 15:35 (SD=4:27) minutes. Students rated 
the length and clarity of the survey as adequate. Students reported moderate to severe 
symptoms of: depression (37%), anxiety (45%), and stress (30%) for the previous week. 
We collected complete data on sleep quality, substance use, pain, and food insecurity. 
Therefore, it is feasible to conduct an internally valid survey of mental health and 
wellness in undergraduate students. 



















Mental health is a growing public health problem in university students (Ibrahim, 
Kelly, Adams, & Glazebrook, 2013; Storrie, Ahern, & Tuckett, 2010). In Canada, the 
prevalence of disabling depression among university students increased from 37.5% in 
2013 to 44.4% in 2016, and the prevalence of overwhelming anxiety grew from 56.5% in 
2013 to 64.5% in 2016 (American College Health Association [ACHA], 2013, 2016). In 
2016, 59.6% of students reported “feeling hopeless”, 13.0% experienced suicidal 
ideation, 8.7% reported self-harm, and 2.1% reported to have attempted suicide (ACHA, 
2016). 
Little is known about the etiology of mental health problems in university 
students; however, cross-sectional studies suggest that they are associated with substance 
use, poor sleep quality, food insecurity, spinal pain, and physical inactivity (Bruening, 
Brennhofer, van Woerden, Todd, & Laska, 2016; Harbour, Behrens, Kim, & Kitchens, 
2008; Hershner & Chervin, 2014; Keith, Hart, McNeil, Silver, & Goodwim, 2015; 
Kennedy, Kassab, Gilkey, Linnel, & Morris, 2008; Robertson, Kumbhare, Nolet, Srbely, 
& Newton, 2017; Samaranayake, Arroll, & Fernando, 2014; Zullig & Divin, 2012). The 
impact of poor mental health in university students is significant; it is associated with low 
grade point averages, poor academic performance, low retention, early drop-out from 
university, antisocial behaviours, substance use and suicide (Cranford, Eisenberg, & 
Serras, 2009; DeBerard, Scott, Spielmans, & Julka, 2004; Hysenbegasi, Hass, & 
Rowland, 2005; Keith et al., 2015; Kwan, Arbour-Nicitopoulos, Duku, & Faulkner, 2016; 
Zullig & Divin, 2012). Studying mental health in university students can be challenging. 
This is partly due to personal, cultural and public stigma associated with mental health 
that may prevent students from participating (Eisenberg, Downs, Golberstein, & Zivin, 
2009; Eisenberg, Hunt, Speer, & Zivin, 2011). Previous studies demonstrate low response 
rates of between 11-28% (Kwan et al., 2016; Lovell, Nash, Sharman, & Lane, 2015). Our 
objective was to test the feasibility of recruitment and to collect valid and reliable mental 
health and wellness data in a sample of undergraduate students enrolled in the Faculty of 
Health Sciences. We aimed to determine participation rate, time to complete, clarity, 





2.3.1 Study design and source population 
We conducted a pilot cross-sectional study of undergraduate students enrolled at 
the University of Ontario Institute of Technology (UOIT) in March 2017. UOIT is a 
publically funded research university located in Oshawa, Ontario. In 2016, the university 
included 9,405 students enrolled in seven faculties with a highly diverse student 
population: 46.6% of students are visible minorities, 82% are between the ages of 18-24, 
59.1% are female (2.3% non-binary) and 46.3% are first-generation university students 
(parent(s) or guardian(s) did not attend or successfully complete post-secondary studies) 
(Office of Institutional Research and Analysis [OIRA], 2017).  
Our pilot study included undergraduate students enrolled in the Faculty of Health 
Sciences. Twenty percent (1963 students) of the university’s student population was 
enrolled in the Faculty of Health Sciences (OIRA, 2017). The faculty includes the 
following programs and specializations: Allied Health Sciences, Health Science (Human 
Health Science and Public Health), Kinesiology (Exercise Science, Health and Wellness, 
and Rehabilitation), Nursing, Medical Laboratory Science, and Fitness and Health 
Promotion. 
2.3.2 Study sample 
To be included, students had to be at least 18-years-old and enrolled in the 
Faculty of Health Sciences. We recruited participants from three classes in Nursing (third 
year class), Kinesiology (third year class), and Health Science (first year class) programs 
over a one week period (March 23rd, 24th and 29th, 2017). 
2.3.3 The Mental Health and Wellness Questionnaire 
We developed an online survey questionnaire, after reviewing the pertinent 
literature and in consultation with subject-matter experts at the University. We designed 
the survey instrument to measure the presence of symptoms of depression, anxiety, and 
stress, and the impact on function, and modifiable lifestyle factors (Lovibond & 
Lovibond, 1995; World Health Organization [WHO], 2017). Our questionnaire included 
valid and reliable questions and instruments to measure sleep quality, physical activity, 
substance use, food insecurity, spinal pain, and socio-demographic variables (Backhaus, 
Junghanns, Broocks, Riemann, & Hohagen, 2002; Bickel, Nord, Price, Hamilton, & 




2005; Craig et al., 2003; Gallasch & Alexandre, 2007; Grandner, Kripke, Yoon, & 
Youngstedt, 2006; Gryczynski et al., 2015; Gulliford, Mahabir, & Rocke, 2004; 
Humeniuk & Ali, 2006; Lee, Macfarlane, Lam, & Stewart, 2011; Statistics Canada, 
2016). 
Symptoms of depression, anxiety and stress 
We selected the Depression Anxiety Stress Scales -21 item (DASS-21) to 
measure symptoms of depression, anxiety, and stress in the past week (Lovibond & 
Lovibond, 1995). The DASS-21 is a self-administered scale designed for nonclinical 
populations, and includes three subscales (symptoms of depression/DASS-D, 
anxiety/DASS-A and stress/ DASS-S). Each subscale contains seven items each, scored 
from ‘0’ (Does not apply to me) to ‘3’ (Applied to me very much or most of the time), for 
a total score of 21. The total score is multiplied by two to fit the original scoring 
developed for the DASS-42. The DASS-21 has adequate psychometric properties and has 
been validated and used in a range of cultures and age groups, including university 
students (Henry & Crawford, 2005; Mahmoud, Lynne, & Staten, 2010; Norton, 2007; 
Sinclair et al., 2012). 
Impact of symptoms of depression, anxiety and stress on function 
We used four questions from the ‘functioning’ section of the World Health 
Organization’s (2017) Model Disability Survey to measure the impact of symptoms of 
depression, anxiety and stress and ability to cope with problems in daily life (questions 
I4024m, I4025, I4030, and I4031). The Model Disability Survey was developed to 
standardize the measurement of health and disability across cultures, providing insight 
into challenges that may arise due to the environment in which one is living, or, because 
of the attitudes or behaviours of people around them. Response options to these questions 
are offered through a Likert scale ranging from ‘1’ (no problem) to ‘5’ (extreme 
problem). These questions have adequate reliability (WHO, 2017). 
Sleep quality 
The Pittsburgh Sleep Quality Index (PSQI) was used to measure overall sleep 
quality. The PSQI provides a standardized, reliable and valid measure of sleep quality 
that distinguishes between ‘good’ and ‘poor’ sleepers (Backhaus et al., 2002; Buysse et 




factors such as sleep duration, sleep efficiency, subjective sleep quality, sleep latency, 
sleep medication, sleep disturbances and daytime dysfunctions. The scale contains 19-
self-rated items grouped into seven component scores, with each weighted on a ‘0’ to ‘3’ 
scale. The total sleep score is the sum of the seven component scores (ranging from 0 to 
21). A total score < 5 is associated with good sleep quality, while a total score ≥ 5 is 
associated with poor sleep quality. The PSQI demonstrates adequate psychometric 
properties and is valid and reliable in adults (Backhaus et al., 2002; Grandner et al. 2006). 
Physical activity 
We used the seven-item version of the International Physical Activity 
Questionnaires (IPAQ) to collect information on time spent: 1) walking; 2) vigorous-
intensity activity; 3) moderate-intensity activity and 4) sedentary activity in the past 7 
days (Lee et al., 2011). The IPAQ total score is calculated through Metabolic Equivalent 
of Task (MET)-min per week (a product of the MET level, minutes of activity, and 
events per week), and classified as low, moderate, and high. The moderate category 
includes individuals who engage in vigorous activity (minimum 20 minutes per day) for 
three or more days. Similarly, the high category includes individuals who spend a 
minimum of three days engaging in vigorous-intensity activity, while accumulating at 
least 1500 MET-minutes/week. The IPAQ shows broad variation in cross-cultural 
validity and reliability in adults; therefore, we aimed to test the tool in our population 
(Craig et al., 2003; Lee et al., 2011). 
Substance use 
We selected the WHO’s Alcohol, Smoking and Substance Involvement Screening 
Test (ASSIST) screening questionnaire to measure the use of psychoactive substances 
(Humeniuk & Ali, 2006). The ASSIST questionnaire consists of eight items including 
tobacco, alcohol, cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, 
hallucinogens, opioids and ‘other drugs’. The ASSIST measures substance use in an 
individual’s lifetime and past three months. It is cross-culturally validated, reliable and 
useful to classify individuals in three categories: 1) low risk substance user or abstainers; 
2) those whose patterns of substance use put them at risk, or already had or were at risk 
of developing problems related to their use; and 3) those who were dependent on a 





We measured food insecurity using the six-item Household Food Security Scale 
Module (HFSSM) (Bickel et al., 2000). The HFSSM, and variations of it, are most 
commonly used when measuring food security status among university student 
populations across a range of cultural groups (Bruening et al., 2016; Hughes, 
Serebryanikova, Donaldson, & Leveritt, 2011; Pia Chaparro, Zaghloul, Holck, & Dobbs, 
2009). The tool uses a prevalence period of the last 12 months, and has been shown to 
approximate closely the three main categories of food security status: ‘food secure’, ‘food 
insecure without hunger’, and ‘food insecure with hunger’. Respondents are classified 
into a food security status based on the sum score that is calculated by the total number of 
affirmative responses. A sum score between ‘0’ to ‘1’ suggests high food security (‘food 
secure’), 2 to 4 suggests low food security (‘moderate food insecurity’), and 5 to 6 
suggests very low food security (‘severe food insecurity’). The six-item HFSSM has 
adequate psychometric properties (Gulliford et al., 2004). 
Spinal pain 
We provided a mannequin diagram to identify the neck and low back region. We 
used the numeric pain rating scale (NRS) to measure back and neck pain intensity. The 
NRS is an 11 point scale and segmented version of the visual analog scale, in which a 
respondent selects a whole number (0 to 10 integers) that best reflects the intensity of 
their pain (Childs et al., 2005). The numbers are arranged in a horizontal line with ‘0’ 
representing no pain and ‘10’ representing worst pain imaginable. Respondents report 
average pain intensity over the past seven days, once for low back pain and again for 
neck pain. The NRS has been tested in a variety of cultural groups with high test-retest 
reliability, acceptable construct validity (strongly correlated to Visual Analogue Scale 
[VAS] scores) and scores that are responsive to change (Gallasch et al., 2007). 
Socio-demographic variables 
Socio-demographic information was collected through questions drawn from 
Statistics Canada (2016). Information included: age, gender, program of study, year of 
study, diagnosed underlying medical conditions, marital status, number of dependents, 




living arrangement, commute time, citizenship, parents’ marital status and parents’ 
employment status. 
Comorbidities 
Information regarding comorbidities was assessed using a list of 26 items 
inquiring about chronic health conditions included in Ontario Common Assessment of 
Needs and the Canadian Community Health Survey (Ontario Common Assessment of 
Need [OCAN], 2017; Statistics Canada, 2015). Medically diagnosed conditions include 
allergies, anxiety, arthritis, asthma, attention disorder/learning disability, eating disorder, 
hypertension, intestinal or stomach ulcers, migraine headaches, mood disorder, scoliosis, 
and sexually transmitted infections. 
Feasibility of administering the questionnaire 
We added four questions to assess the ease of administration of the questionnaire. 
The first question inquired about the length of the questionnaire. Students were asked to 
rate the length of the questionnaire on a 10 point numerical rating scale with ‘0’ 
indicating that the questionnaire was “too short” and ‘10’ indicating “too long”. We also 
asked students to rate the clarity of the questionnaire, in which ‘0’ indicated that the 
questionnaire was “unclear” and ‘10’ indicated that it was “clear.” The third question 
asked students for open-ended feedback regarding the constructs addressed in our 
questionnaire. The fourth question asked students for general comments on additional 
areas relevant to mental health and wellness that were not addressed directly in the 
questionnaire. 
2.3.4 Recruitment and data collection 
We administered the pilot survey in three undergraduate classes. Students were 
informed of the study prior to attending class on the designated survey date and were 
given the opportunity to review the informed consent form. At the beginning of each 
class, the research team introduced the study with a short presentation. Students who 
were interested in participating were instructed to access a link to the consent form and 
questionnaire, using their student access login. Students who chose not to participate 
were asked to remain seated. This was done to minimize the risk of identifying students 






We analysed the data using SPSS 24.0 (IBM SPSS Statistics, 2016). Descriptive 
statistics were computed to describe the distribution of all the variables. We used NVivo 
version 11 to conduct content analysis of student responses to open-ended questions in 
the feedback portion of the questionnaire (NVivo qualitative data analysis, 2016). 
Feedback content was analysed by categorizing responses into themes based on 
descriptive similarities and differences. Content analysis was conducted to make sense of 
the feedback collected, in order to highlight key messages retrieved from students (Elo & 
Kyngas, 2008). 
2.4 RESULTS 
2.4.1 Sample characteristics 
172 students were eligible for the study and 137 participated (80%). The 
participation rates across the three classes were 85% (in Health Science), 82% (in 
Nursing), and 72% (in Kinesiology). Seventy-five percent of our sample were female. 
The mean age was 22 years (SD=3.41). Thirty-six percent of the sample were nursing 
students, 33% kinesiology students and 14% health science students. Most of our sample 
were first- and third-year students (52%). With respect to income, over 75% of our 
students reported an annual personal income under $10,000, and 50% reported working 1 
to 19 hours/week. Two-thirds of the students reported an academic average of 70-85% in 
the previous academic year. 
2.4.2 Feasibility 
On average, it took 15:35 minutes (SD=4:27) to complete the questionnaire. The 
mean rating of the length of the survey was 6.5/10 (SD=1.9) suggesting that students 
were satisfied with the length of the questionnaire. The mean clarity rating was 8.4/10 
(SD=2.20) suggesting that students were satisfied with the clarity of the questions. 
2.4.3 Symptoms of depression, anxiety and stress 
Overall, 50.0% (95% CI: 41.6-58.4) of participants experienced symptoms of 
depression in the past week. Similarly, 62.0% (95% CI: 53.9-70.1) experienced 
symptoms of anxiety and 42.0% (95% CI: 33.7-50.3) experienced symptoms of stress 
(Table 1). In the past week, 37.0% (95% CI: 28.9-45.1) of participants experienced 




experienced moderate-extremely severe symptoms of anxiety, and 30.0% (95% CI: 23.3-
37.7) experienced moderate-extremely severe stress-like symptoms (Table 1). 
2.4.4 Sleep quality 
Eighty percent (95% CI: 73.3-86.7) of participants experienced poor sleep quality 
in the past week. On average, participants spent 8.05 hours (95% CI: 7.57-8.52) in bed; 
however, 34.0% (95% CI: 26.0-41.9) reported experiencing 6-7 hours of actual sleep and 
28.0% (95% CI: 20.5- 35.6) reported experiencing 5-6 hours of actual sleep. Most 
participants (60.0%; 95% CI: 51.8- 68.2) required between 16-60 minutes to fall asleep. 
2.4.5 Substance use 
Alcohol (76.9%; 95% CI: 72.9-86.4) and marijuana (51.1%; 95% CI: 42.7-59.5) 
were the most commonly used substances in the participants’ lifetime (Table 2). 
Similarly, alcohol (71.5%; 95% CI: 63.9-79.1) and marijuana (32.1%; 95% CI: 24.3-
39.9) were the most commonly used substances in the past three months. Finally, 7.3% 
(95% CI: 2.9-11.7) and 5.8% (95% CI: 1.9- 9.7) of participants reported to have used 
sedatives and hallucinogens respectively during their lifetime. 
2.4.6 Food insecurity 
Our data suggest that 23.0% (95% CI: 16.0-30.1) of participants experienced 
either low food security or very low food security in the past 12 months. Low and very 
low food security can include behaviours ranging from compromising on the quality or 
quantity of food, cutting the size of meals, and skipping meals. Specifically, 25.0% (95% 
CI: 17.8-32.3) of participants reported being unable to afford balanced meals, 10.0% 
(95% CI: 5.0-15.0) have cut the size of meals, and 13.0% (95% CI: 7.4-18.6) have been 
hungry but unable to eat due to financial constraints. 
2.4.7 Spinal pain 
In the past week, 70% (95% CI: 62.3-77.7) of participants reported to have 
experienced low back pain and 68% (95% CI: 60.2-75.8) reported neck pain. Participants 
with low back pain reported a mean pain intensity of 3.8/10 (95% CI: 3.4-4.2). Similarly, 
those with neck pain reported a mean intensity of 3.7/10 (95% CI: 3.3-4.2). 
2.4.8 Comorbidities 
Fifty-eight percent (95% CI: 49.7-66.3) of participants reported a medical 




diagnosed conditions, and 2.0% (95% CI:-0.3-4.3) of students had five diagnosed 
conditions. The most common comorbidities were allergies, asthma and anxiety (Table 
3). 
2.5.9 Physical activity 
Most data on physical activity was of poor quality, which prevented the 
computation of descriptive statistics. Feedback from the participants suggested that the 
wording of the IPAQ was very ambiguous, thereby contributing to the poor data that was 
reported. Specifically, the structure of the questions was problematic for participants. 
Participants indicated that the IPAQ items lacked consistency and clarity, requesting both 
daily and weekly estimates of physical activity to be reported. We were nevertheless able 
to analyse responses from one question: “During the last 7 days, on how many days did 
you walk for at least 10 minutes at a time?” Most participants (95.0%; 95% CI: 91.4-
98.7) reported that they perform at least 10 minutes of walking on any day of the week. 
2.4.10 Feedback and revisions for Cross-Sectional Study 
Overall, respondents were satisfied with the study. Students’ feedback included 
comments such as: “The questionnaire is very detailed and clear”, “Great job”, and 
“Good variety of questions.” Respondents also provided suggestions regarding others 
areas of mental health and wellness, important to them, and not currently addressed in the 
survey. Content analysis generated three general themes: 1) academic 
performance/school-related stressors, 2) ability to cope, and 3) social support systems. 
Students primarily provided feedback regarding academic performance/school-related 
stressors. Students suggested that the burden of academic work is an important area of 
student mental health and wellness. Therefore, our questionnaire should include questions 
that address students’ academic life. Similarly, respondents stated that our questionnaire 
should inquire about coping strategies to recognize and capture a wide scope of students’ 
diverse approaches to coping. Finally, respondents identified social networks and 
interpersonal relationships as a significant area of student mental health and wellness. 
Students indicated that the questionnaire should inquire about their capacities to build and 





Our pilot study aimed to determine the feasibility of conducting a cross-sectional 
survey to assess the association between modifiable lifestyle factors and symptoms of 
depression, anxiety and stress in undergraduate university students. The results suggest 
that our recruitment and data collection methodologies are acceptable for in-class 
administration in university students. In our sample of students, participants completed 
the questionnaire within an average of 15 minutes. Therefore, it is suitable for the 
questionnaire to be administered during traditional face-to-face class time, with minimal 
disruption. The participation rates of eligible students in our three pilot administrations 
suggest that students are interested in the study. Moreover, students’ feedback 
demonstrates that students appreciated the opportunity to participate, and find that the 
questionnaire is easy to navigate, and that its length is appropriate. The open-ended 
feedback suggests that the questionnaire’s content resonated with students. Favorable 
feedback indicates that students are satisfied with the objectives of this study in that they 
consider these issues both timely and important. For follow-up studies, it may be relevant 
and useful to assess the feasibility of administering the questionnaire in a fully online 
learning environment, and to use qualitative approaches including individual interviews 
and focus group interviews with university students to explore and capture these issues. 
The Mental Health and Wellness study addresses an important gap in the 
literature by investigating the multidisciplinary nature of mental health and wellness in 
university students. The results of our study suggest the need for further research; our 
pilot study is the first in a series of investigations to better understand university student 
mental health and wellness. 
2.5.1 Post-pilot modifications to questionnaire 
Based on feedback from participants and the pilot study results, we modified the 
questionnaire as described below: 
(1) The International Physical Activity Questionnaire (IPAQ) will be replaced with the 
Physical Activity and Sedentary Behaviour Questionnaire (PASB-Q). We encountered 
ambiguous data using the IPAQ to gather information on physical activity. The responses 
retrieved from this portion of the questionnaire did not match the format of the question, 
as many required respondents to include days, hours, and minutes spent running, walking 




physical activity set of questions. Prior research has suggested that the IPAQ is not an 
accurate indicator of physical activity and has shown inconsistent results; this was borne 
out in our population as well (Lee et al., 2011). To rectify this, we will use the PASB-Q 
to measure physical activity and sedentary behaviour. The PASB-Q was developed by the 
Canadian Society for Exercise Physiology (CSEP) to measure the one-week prevalence 
of physical activity and sedentary behaviour in adults. The questionnaire measures 
sedentary behaviour, moderate activity and vigorous activity, and each of the seven items 
are scored based on self-report in minutes, hours, days, and frequencies. An early study 
suggests that the PASB-Q demonstrates adequate reliability and validity (Fowles, 
O'Brien, Wojcik, d'Entremont, & Shields, 2017). 
(2) Additional examples and street names of substances in the “amphetamine-type 
stimulants”, “sedatives and sleeping pills”, and “opioids” sections of the ASSIST tool 
will be included to ease comprehension of the substance use section. “Employment status 
of your [father/male] and [mother/female] guardian” questions will be altered to allow 
answers for 30 same sex and single parents. Both revisions are a response to feedback by 
coinvestigators and students. 
(3) We will remove the diagnosed conditions that had a very low prevalence rate in pilot 
study findings (<5%), and present the remaining list of conditions for the comorbidities 
question in alphabetical order to ease clarity. This will eliminate conditions not typically 
seen in this population (e.g. cancer) and allow students to navigate this question with 
greater ease. 
(4) Applicable items from the Student University Satisfaction Scale (SUSS) and the 
Social Provisions Scale (SPS) were selected and will be incorporated into the 
questionnaire (Bhamani & Hussain, 2012; Cutrona & Russell, 1987). These will be added 
in response to student feedback suggesting the inclusion of constructs that address student 
satisfaction with the university, and social support systems. Further, the SPS has adequate 
psychometric properties (Cutrona & Russell, 1987). 
2.5.2 Strengths 
First, our questionnaire was developed with the use of valid and reliable 
instruments to measure symptoms of depression, anxiety, and stress, food insecurity, 




participation rates among class attendees were high (80%). Third, the completion time for 
the questionnaire was reasonable which suggests that it is feasible to administer the 
questionnaire in class with minimal disruption. 
2.5.3 Limitations 
Our recruitment strategy only recruited students who attended class. Although 
399 students were enrolled in the three classes, 172 students attended classes (on the days 
that the survey was administered) and were eligible to participate in the pilot 
questionnaire. Because we did not have data on those who did not attend classes, we are 
unable to comment on the reasons for non31 participation. Moreover, the results of our 
pilot study are not generalizable to a more diverse population of students. The purpose of 
our pilot study was not to produce generalizable results; rather, it was to understand the 
feasibility of conducting a cross-sectional study and obtain preliminary estimates of the 
prevalence of mental health symptoms and lifestyle factors. Finally, we are unable to 
comment on the level of physical activity on our pilot sample as we obtained unreliable 
data in the physical activity portion of our questionnaire. Therefore, it is likely that the 
physical activity questions in the pilot version of the questionnaire (retrieved from the 
IPAQ) are associated with measurement error. 
2.5.4 Conclusion 
Our pilot study suggests that it is feasible to administer an in-class questionnaire 
to study mental health and wellness among university students. Findings from the pilot 
study suggest that there is a concerning prevalence of symptoms of depression, anxiety 
and stress in this population. The survey also documented the prevalence of food 
insecurity, substance use, poor sleep quality, and spinal pain. In our next administration, 
we aim to obtain class rosters to secure demographic information on enrolled students, in 
order to assess differences between our sample and the overall population. This pilot 
study has informed changes to improve the clarity of the questionnaire, and preliminary 
results have suggested that continued investigation is necessary to understand the 
prevalence and association of symptoms of depression, anxiety and stress with various 
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Table 1. One-week prevalence (95% CI) of symptoms of depression, anxiety, and stress. 
 Depression Anxiety Stress 
Normal 50.0% (41.6-58.3) 38.0% (29.9-46.1) 58.0% (49.7-66.3) 
Mild 13.0% (7.4-18.6) 16.5% (10.3-22.7) 12.0% (6.6-17.4) 
Moderate 26.0% (18.7-33.3) 17.5% (11.1-23.9) 19.0% (12.4-25.6) 
Severe 7.0% (2.7-11.3) 10.0% (5.0-15.0) 9.0% (4.2-13.8) 

























Table 2. Lifetime and three-month period prevalence (95% CI) of substance use. 
Substance
1
 Lifetime use Past three month use 
 
Alcohol 79.6% (72.9-86.4) 71.5% (63.9-79.1) 
 
Marijuana 51.1% (42.7-59.5) 32.1% (24.3-39.9) 
 




9.5% (4.6-14.4) 4.4% (0.9-7.8) 
 
Sedatives 7.3% (2.9-11.7) 2.2% (-0.3-4.7) 
 
Opioids 6.6% (2.4-10.8) 2.9% (0.1-5.7) 
 
Cocaine 4.4% (0.9-7.8) 1.5% (-0.5-3.5) 
 
Hallucinogens 5.8% (1.9-9.7) 0.7% (-0.7-2.1) 
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Allergies 24.0% (18.7-33.3) 
Asthma 20.0% (13.3-26.7) 
Anxiety 17.0% (10.7-23.3) 
Scoliosis 10.0% (10.7-23.3) 
Mood disorder(s) 9.0% (4.2-13.8) 
Migraine headaches 7.0% (2.7-11.3) 
ADD/ADHD – learning disability 5.0% (1.4-8.7) 
1
No participant reported the following comorbidities: arthritis, bowel disorder(s), cancer, 
chronic bronchitis, emphysema, chronic obstructive pulmonary disorder (COPD), chronic 
fatigue syndrome, diabetes, eating disorder(s), fibromyalgia, heart disease, high blood 
pressure, intestinal or stomach ulcers, multiple chemical sensitivities, personality 
























CHAPTER 3: MANUSCRIPT 2 
TITLE: IS NON-MEDICAL USE OF PRESCRIPTION SEDATIVES AND 
SLEEPING PILLS ASSOCIATED WITH SYMPTOMS OF DEPRESSION, 



































Little is known about the lifestyle behaviors associated with poor mental health in 
undergraduate university students. Non-medical use of sedative and sleeping pills may be 
associated with poor mental health in this population. I aimed to determine whether non-
medical sedative and sleeping pill use is associated with symptoms of depression, 
anxiety, and stress in undergraduate students at the University of Ontario Institute of 
Technology (UOIT).  
Methods 
I conducted a cross-sectional study of undergraduate students enrolled in the faculty of 
health sciences (FHS) and faculty of education (FEd) at UOIT in the Fall semester of 
2017. Non-medical sedative and sleeping pill use in the past three months was measured 
with the Alcohol, Smoking, and Substance Involvement Screening Test and symptoms of 
anxiety, stress and depression in the past seven days were measured with the 21-item 
version of the Depression, Anxiety, and Stress Scale. I used multivariable logistic 
regression to measure the associations while controlling for covariates.  
Results 
My sample included 882 students and 3.7% (95% CI [2.6, 5.2]) reported non-medical 
sedative and sleeping pill use in the past three months. Overall, 30.3% (95% CI [27.3, 
33.4]), 47.3% (95% CI [43.9, 50.6]), and 25.5% (95% CI [22.7, 28.5]) reported moderate-
extremely severe symptoms of depression, anxiety, and stress in the past seven days. My 
multivariable logistic regression analysis suggests that non-medical sedative and sleeping 
pill use is not associated with moderate-extremely severe symptoms of anxiety, stress, 
and depression. 
Conclusions 
My cross-sectional analysis suggests that non-medical sedative and sleeping pill use are 
not associated with symptoms of anxiety, stress, and depression in two faculties at UOIT. 
Nevertheless, students must be educated about the potential negative health impacts of 






Symptoms of depression, anxiety, and stress are common in undergraduate 
university students. According to the 2016 National College Health Assessment 65.4% of 
Ontario university students reported experiencing “overwhelming anxiety” in the past 12 
months; 46.1% reported feeling “so depressed it was difficult to function”; and 42.9% 
reported stress had an impacted their academic
1
. This problem is not specific to Canada.  
In the United States, the lifetime prevalence of diagnosed depression and anxiety in 
university students are 14% and 13%, respectively
2
. Other studies from the United States 
and Australia report that the two-week prevalence of depression ranges from 8% to 18%, 
and 13% to 21% report symptoms of anxiety in the same period
3, 4
. Finally, the one-week 
prevalence of symptoms of depression, anxiety, and stress were 22%, 29%, and 27% 
respectively in students from Australia
5 
Anxiety, stress, and depression may have a significant negative impact on 
academics and the health and welfare of undergraduate university students. Specifically, 
the evidence suggests that poor mental health is associated with lower academic 




Moreover, an association between mental 
health and self-harm, risk of suicide, smoking, alcohol and drug use has been reported
7-12
.   
The etiology of anxiety, depression, and stress in university students is poorly 
understood but it is hypothesized that the non-medical use of prescription medications 
may be a risk factor
11,13-15
. Non-medical use refers to the use of medications not 
prescribed to an individual or using medications beyond what is prescribed. The non-
medical use of medications may be motivated by several factors including poor sleep 
quality, coping with anxiety or stress, and getting high
13-15
. The non-medical use of sleep 
and anxiety medications are of particular concern because it is associated with significant 
negative health outcomes including risk of overdose and dependence, early mortality, and 
cognitive declines
16-18
. In Ontario in 2015, 2.1% of university students reported using a 
sedative medication that was not prescribed to them in the past year
1
. This is consistent 
with studies from the United States, where 2.3% and 3% of university students reported 
using sleeping and anxiety medications respectively without a prescription in the past 
year
19








To date, few epidemiological studies have investigated the association between 
non-medical sedative and sleeping pill use and symptoms of depression, anxiety, and 
stress in university students. Overall these studies report an association between sedative 
use and depression, anxiety, and/or stress
11,20,21
. However, previous studies had 
limitations.  First, previous studies used heterogeneous definitions of sedatives and sleep 
medications
11,23-26
. Second, some studies examined only one type of medication (such as 
benzodiazepines) while others investigate combination of benzodiazepines, barbiturates, 
or non-benzodiazepine drugs (z-drugs)
11,20,21
. Third, previous studies did not use 
psychometrically sound instruments to assess the presence of mental health
11,20,21
. Lastly, 
there are concerns about the representativeness of the samples in previous studies. For 
example, one study using the ACAH data reported a response rate of 27% from 
participating schools
11
. Another study only surveyed nurses from the school
20
 and another 
used a convenience sample of students that were not representative of the overall school 
population
21
. Therefore, my thesis aimed to address the limitations of previous studies by 
using valid and reliable measurement instruments. The objective of this paper was to 
determine whether non-medical sedative and sleeping pill use in the past three months is 
associated with moderate to extremely severe symptoms of depression, anxiety, and 
stress in undergraduate students enrolled in the faculty of health sciences and faculty of 
education at UOIT during the Fall term of 2017. 
 
3.3 METHODS 
3.3.1 Study Design and Study Population 
I conducted an analysis of the Mental Health and Wellness Study, a cross-
sectional study of undergraduate students enrolled in the faculty of health sciences and 
the faculty of education at UOIT. The study was conducted from September 26th to 
October 23rd, 2017. It was approved by the UOITEthics Board (REB #14310 and REB 
File #14515). 
UOIT is a public research university located in Oshawa, Ontario. In the 






. Twenty percent of this population (1931 students) were enrolled in a 
program within the faculty of health sciences, and four percent (363 students) were 
enrolled in the faculty of education
27
.  Five percent of undergraduate students were 
international students and 46.3% were first-generation university-goers
27
.  
The faculty of health sciences includes nine specific programs (Allied Health 
Sciences, Health Science (Human Health Science and Public Health), Kinesiology 
(Exercise Science, Health and Wellness, and Rehabilitation), Nursing, Medical 
Laboratory Science, and Fitness and Health Promotion). The faculty of education offers 
two undergraduate: bachelor of arts in educational studies and digital technology, and the 
bachelor of education. Students enrolled in the faculty of health sciences and faculty of 
education, bachelor of education program (n=268) were eligible for the study. 
 
3.3.2 Study Sample and Recruitment  
Students eligible for the study were 18 years of age or older and able to complete 
the study survey online. Participants were recruited in three sequential waves (Appendix 
C).  In wave 1, participants were recruited during mandatory classes for their program. 
For example, Anatomy and Physiology are a required course during the first semester of 
many of the programs in the faculty of health sciences. In the faculty of health sciences, 
21 in-person and four online classes were used for recruitment while two classes were 
used in the faculty of education.  One week prior to wave 1 recruitment, emails were sent 
to class instructors and students to explain the purpose of the study and data collection 
process. On the day of the survey the research team attended class and explained the 
purpose of the study to students (Appendix D). The same information was provided to 
students attending classes on-line but it was delivered in a short video posted on the 
class’ educational software. 
Students who did not attend class on the day of wave 1 recruitment were provided 
the opportunity to participate in a second wave of recruitment. In wave 2, class 
instructors posted a link to the survey questionnaire on the class’ educational software. In 
wave 3, the deans of the faculty of health sciences and faculty of education emailed all 
students and invited them to participate in the survey; the email included a link to the 




campaign was launched using UOIT (faculty of health sciences, faculty of education) 
Facebook and faculty of health sciences and faculty of education (& CDPR) twitter 
accounts to remind students about the study. Throughout the recruitment period, posters 
informing students about the study were placed at university’s Student Services office, in 
the faculty’s offices and at the university outreach centre. 
 
3.3.3 Data Collection 
Students, who were interested in participating in the survey, were asked to use 
their computers or portable device to access the online survey questionnaire. Prior to 
having access to the survey, students were asked to read a consent form and provide 
informed consent to participate in the study. Once they provided consent, they were 
directed to the survey. The online study questionnaire included eight sections (Appendix 
E). Each section included standardized valid, reliable, questions and instruments that 
have been cross-culturally validated.  Students who completed the survey were not able 
to access the link again. No compensation was provided for participation. As explained in 
the consent form, the aggregate results of the study will be disseminated to students 
following the completion of the analysis.  
 
3.3.4 Independent Variable: Non-medical Sedative and Sleeping Pill Use 
Substance use was measured using the Alcohol, Smoking, and Substance 
Involvement Screening Test (ASSIST, v3.0)
16,28
. The ASSIST was developed by the 
World Health Organization to measure non-medical use lifetime and three month use of 
tobacco products; alcohol, cannabis, cocaine; amphetamine-type stimulants; sedatives 
and sleeping pills; hallucinogens; inhalants; opioids; “other” drugs. It allows respondents 
to select use daily, weekly, monthly, one or twice, or never in response to whether they 
have used in the past 3 months. My thesis focuses on the lifetime use and use in the past 
three months of sedative and sleeping pills.  Students who reported to have used daily, 
weekly, monthly, or once or twice were classified as users. The ASSIST has adequate 
validity and reliability in a range of populations
29-31
. In order to make the ASSIST more 
relevant and to elicit more accurate responses the list of example sedative and sleeping 




Canada. Several names were added along with their street names (Kept: Valium, 
Rohypnol; Added: Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets; Removed: Serepax).  
 
3.3.5 Dependent Variables: Symptoms of Depression, Anxiety and Stress 
The Depression Anxiety Stress Scales-21 (DASS-21) was used to measure 
symptoms of depression, anxiety and stress ‘over the past week’
32
. The DASS-21 is a 
self-administered tool used to measures symptoms of depression, anxiety and stress in the 
past week
33
. It includes 21 questions divided in three subscales (seven questions each for 
symptoms of depression, anxiety and stress).  The total score for each subscale is used to 
classify participants into five categories: normal, mild, moderate, severe, and extremely 
severe symptoms. For the purpose of my thesis, I dichotomized participants into two 
categories those who were with moderate-extremely severe symptoms versus those with 
normal and mild symptoms. The DASS- 21 has adequate reliability and validity in a 





Socio-demographics: Twenty-two questions from Statistics Canada
40
 and the Canadian 
Community Health Survey
41
 and the ACHA
1
 were used to collect socio-demographic 
variables. These questions collected information on age, gender, marital status, number of 
dependents, academic average, program and year of study, income (personal & 
household), hours/week paid work, living arrangement, commute to university, Canadian 
citizenship, domestic or international student status, ethnic/cultural ancestors’ origin, 
parents’ marital and employment status. 
Comorbidities: The following self-reported diagnosed health conditions were measured 
using questions from the Canadian Community Health Survey
41
 and the Ontario 
Common Assessment of Need
42
: allergies, anxiety, arthritis, asthma, attention 
disorder/learning disability, eating disorder, hypertension, intestinal or stomach ulcers, 
migraine headaches, mood disorder, scoliosis, and sexually transmitted infections. 
Mental health disability: Self-reported disability in the past 30 days related to 




Health Organization Model Disability Survey
43
 (questions I4024m, I4025, I4030, and 
I4031). The questions asked “How much of a problem do you have with feeling sad, low 
or depressed?”; “How much of a problem do you have with feeling worried, nervous or 
anxious?”; “How much of a problem is handling stress, such as controlling the important 
things in your life?”; “How much of a problem is coping with all the things you have to 
do?”. Responses were provided on a Likert scale with options ranging from ‘1’ (no 
problem) to ‘5’ (extreme problem). 
Academic environment and social support: Two questions from the Student University 
Satisfaction Scale
44
 were used to assess perceptions of academic environment. Questions 
asked “I find university's learning environment conducive”; and “I find the academic 
policies of my university student-friendly”. Responses were “Never”, “Sometimes”, and 
“Always”. Moreover, two questions from the Social Provisions Scale
45
 were used 
measure social support. These questions asked “I have no close relationships that make 
me feel good”, and “There is no one I feel comfortable talking about my problems with”. 
Responses were “Strongly Disagree”, “Disagree”, “Agree”, and “Strongly Agree”. 
Sleep quality: Sleep quality in the past week was measured with the Pittsburgh Sleep 
Quality Index (PSQI). The PSQI includes 19 questions grouped into 7 components, and 
provides a measure of self-reported sleep quality that distinguishes between ‘good’ and 
‘poor’ sleepers
46,47




Physical activity and sedentary behaviour: The Physical Activity and Sedentary 
Behaviour Questionnaire was used to measure physical activity and sedentary behavior in 
the past week. The PASB-Q provides self-reported measures of physical activity, muscle 
strength, perceived fitness, and sedentary behaviors and classifies individuals as 




Food insecurity: The presence of food insecurity in the past 12 months was measured 
using the six-item Household Food Security Scale Module (HFSSM)
50
.  Food insecurity 
refers to the inability to acquire or consume an adequate or sufficient quantity of food, or 
the uncertainty that one will be able to do so
51,52
. Responses to the six questions are used 








Neck and low back pain: The numerical rating scale (NRS) was used to measure average 
low back and neck pain intensity in the past seven days. A picture of a mannequin was 
provided to ensure that participants referred to standardized locations of the neck and low 
back. Students were asked to select a whole number (0 to 10 integers) on an 11 point 
scale that best reflected the intensity of their pain in the past week
54
. The NRS has 




3.4 PILOT STUDY 
The feasibility of recruiting and collecting data in class in three classrooms was 
tested in the spring of 2017 (See Chapter 2). A total of 137 participants from the faculty 
of health sciences were recruited. The in-class participation rate was 80%. The average 
time of completion was 15:35 (SD=4:27) minute and participants rated the length and 
clarity of the survey as adequate.   
 
3.5 DATA ANALYSIS 
3.5.1 Baseline Characteristics of the Sample and Participation Bias  
 I described the sample by computing the mean and standard deviations for 
continuous variables and proportions for dichotomous and categorical variables. I 
computed participation rates by dividing the number of respondents by the number of 
students enrolled in each faculty in September 2017. I assessed participation bias by 
comparing the study sample to available demographic information (age, gender, domestic 
student status, year of study) obtained from each faculty.  I used t-tests and chi squared to 
compare the characteristics of the samples from the faculty of health sciences and the 
faculty of education.  
 
3.5.2 Prevalence of Mental Health and Sedative Use  
 I computed the one-week prevalence and 95% confidence intervals (CI) for 
moderate to extremely severe symptoms of depression, anxiety, and stress. Similarly, I 




pill use. The number of students who responded to the survey was used as the 
denominator for all prevalence computation. 
 
3.5.3 Association between Mental Health and Sedative Use 
 Logistic regression was used to assess the association between non-medical 
sedative and sleeping pill use in the past three months and moderate-extremely severe 
symptoms of depression, anxiety, and stress in the past week.  Separate models were built 
for symptoms of anxiety, depression, and stress. My modeling strategy included four 
steps. First, I computed the crude association between sedative and sleeping pill use and 
symptoms of depression, anxiety, and stress. Second, I built a series of bivariate models 
to determine whether covariates changed the strength of the crude association (beta 
coefficient). A covariate was retained for step 3 of analysis if its addition to the crude 
model changed the beta coefficient for sedative and sleeping pill use by at least 10%.  
The following variables were considered covariates for the models: age, gender, 
academic average, year of study, ethnicity, marital status, annual income (personal), 
annual income (household), Canadian citizenship, sleep quality, physical activity, 
sedentary behaviour, neck pain, low back pain, medical conditions, diagnosis of a mood 
disorder, food security, alcohol use, marijuana use, cocaine use, and stimulant use. 
Categories within gender, marital status, personal income, household income, and food 
security were collapsed because some categories had few respondents. In the third step, I 
included all covariates that resulted in a 10% change in the crude beta coefficient in a 
final regression model. Finally in the final step, I aimed to build a valid yet parsimonious 
model by removing covariates that did not significantly contribute to the model (p-value 
> 0.05 on the Wald Chi-square test) by removing non-significant variables one at a time 
starting with the least significant one. Only covariates that did not change the beta 
coefficient for sedative and sleeping pill by more than 10% chance were permanently 
removed from the final model (See Appendix E for a flow chart of this process).  
 
3.6 RESULTS 
3.6.1 Participation  




faculty of health sciences and 77% (207/ 268) in the faculty of education.  Although the 
survey targeted students enrolled in the faculty of health sciences and faculty of 
education, 10 students from other faculties (enrolled in courses as electives) completed 
the survey. These students were excluded from the analysis. Overall, participants were 
younger than students enrolled in each of the two faculties, but were similar regarding 
gender, year of study, or residency (Table 1). 
 
3.6.2 Sample Characteristics 
The average age of the entire sample was 23.0 years (SD=5.5), most were females 
(77.1%), and domestic students (98.6%). Most students were single (87.6%) with no 
dependents (73.9%) and a reported income of less than $5,000 (46%) (Table 2).   
Participants from the faculty of health sciences and faculty of education differed 
according to age, gender, ethnicity, neck pain, academic average, and some of the 
substance use and personal, financial, and employment variables (Table 2). However, 
there were no differences between faculties with regards to lifetime prevalence of 
sedative use, 3-month prevalence of sedative use, and one-week prevalence of moderate-
extremely severe symptoms of depression, anxiety, and stress. There was also no 
difference between the faculty with respect to the crude associations between past week 
moderate-extremely severe symptoms of depression, anxiety, and stress and past 3 month 
nonmedical sedative and sleeping pill use (Table 3). The absence of differences in the 
prevalence of the dependent and independent variable suggest that the association of 
interest can be evaluated in the entire sample rather than in each of the faculties 
separately. 
 
3.6.3 Prevalence of Sedative and Sleeping Pills and Symptoms of Anxiety, Stress and 
Depression 
In our sample 7.8% (95% CI [6.1, 9.8]) of respondents reported lifetime non-
medical sedative and sleeping pill use, and 3.7% (95% CI [2.6, 5.2]) reported using 
sedative or sleeping pills in the past three months. When evaluating the prevalence of use 
in the past three months, 2.5% (95% CI [1.6, 3.8]) reported using sedatives or sleeping 






Table 4. Past 3 month prevalence of non-medical sedative and sleeping pill use, and 
frequency of past 3 month use (% of total sample, number of users, 95% CI). 
Frequency of non-medical sedative and sleeping pill use Past 3 Month Use 
Once or Twice                                                                         2.5% (22) [1.6, 3.8] 
Monthly                                                                                     0.5% (4) [0.1, 1.2] 
Weekly                                                                                       0.6% (5) [0.2, 1.3] 
Daily or Almost Daily                                                               0.2% (2) [0, 0.8] 
Total 3.7% (33) [2.6, 5.2] 
 
The one-week prevalence of moderate-extremely severe symptoms of depression 
was 30.3% (95% CI [27.3, 33.4]). Moreover, 47.3% (95% CI [43.9, 50.6]) reported 
moderate-extremely severe symptoms of anxiety in the past week and 25.5% (95% CI 
[22.7, 28.5]) moderate-extremely severe symptoms of stress in the same period. 
 
3.6.4 Crude Association between Sedative and Sleeping Pills Use and Symptoms of 
Depression, Anxiety, and Stress 
 The crude analysis suggests that non-medical use of sedatives and sleeping pills in 
the past three months is not associated with moderate to extremely severe symptoms of 
depression (OR=1.16; 95% CI [0.53-2.54]) or anxiety (OR=0.65; 95% CI [0.32-1.31]). 
However, the use of sedatives and sleeping pills in the past three months was associated 
with moderate to extremely severe symptoms of stress (OR=0.39; 95% CI [0.20-0.80]); 
suggesting that users of sedatives or sleeping pills were less likely to report moderate to 
extremely severe symptoms of stress than non-users.   
 
3.6.5 Adjusted Associations between Sedative and Sleeping Pills Use and Symptoms 
of Depression, Anxiety, and Stress 
 Results for the bivariate models that determined which covariates were included 




covariates included, and adjusted odds ratios are presented in Table 6. 
Moderate to extremely severe symptoms of depression 
The final model included nine covariates and suggests that non-medical sedative 
and sleeping pills use in the past three months is not associated with moderate to 
extremely severe symptoms of depression in the past week (OR=1.30; 95% CI [0.53, 
3.09]) (Table 5). 
Moderate to extremely severe symptoms of anxiety  
Six covariates were included in the final model. The final model suggests that 
non-medical sedative and sleeping pills use in the past three months is not associated with 
moderate to extremely severe symptoms of anxiety in the past week (OR=1.15; 95% CI 
[0.52, 2.55]) (Table 5). 
Moderate to extremely severe symptoms of stress 
The final model included 3 covariates, and suggest that non-medical sedative and 
sleeping pills use in the past three months is not associated with moderate to extremely 
severe symptoms of anxiety in the past week (OR=0.64; 95% CI [0.29, 1.42] (Table 5). 
 
Table 6. Associations between past 3 month sedative use and past week symptoms of 
depression, anxiety, and stress, including covariates used in the final model. 
Past-7 day Symptoms of 
Mental Health (Moderate-
Extremely Severe) 
Variables Included in Final 
Model 
Adjusted Odds Ratios  
(95% CI) 
Depression sleep quality, sedentary 
behaviour, age, gender, 
alcohol, marijuana, neck pain, 
annual income, and household 
income  
1.30 [0.53, 3.09] 
Anxiety mood disorder, age, 
marijuana, stimulant, neck 
pain, and back pain 
1.15 [0.52, 2.55] 
Stress mood disorder, marijuana, 
and neck pain 







3.7.1 Summary of Results 
The association between the non-medical use of sedatives and sleeping pills and 
student mental health was assessed in the UOIT Mental Health and Wellness Cross-
sectional Study. A minority of students reported the non-medical use of prescription 
sedatives and sleeping pills in their lifetime (7.8%) and in the past three months (3.7%). 
However, an important proportion of students reported moderate-extremely severe 
symptoms of depression (30.3%), anxiety (47.3%), and stress (25.5%) in the past week. 
Although I found a crude association between non-medical sedative and sleeping pill use 
and moderate-extremely severe symptoms of stress, this association was explained by 
covariates.  Overall, my results suggest that non-medical sedative and sleeping pill use is 
not associated with moderate-extremely severe symptoms of depression, anxiety, or stress 
in undergraduate students enrolled in the faculty of health sciences and faculty of 
education at the UOIT.  
 
3.7.2 Comparison to Previous Research 
3.7.2.1 Response rate 
 The response rate for my study was 40%. This rate is higher than many previous 
studies of student mental health
1,3,5,24,56
, but is nevertheless suggest that selection bias 
may have influenced the results. However, a comparison of our sample to the university’s 
undergraduate population demonstrates that our sample is representative with regards to 
gender, year of study, and residency status, therefore reducing the chances of selection 
bias.  
 
3.7.2.2 Prevalence of non-medical sedative and sleeping pill use and symptoms of 
depression, anxiety, and stress 
Previous research examining prevalence of sedative use often examines different 
report periods of consumption. Some reported lifetime use
20-22,24,25
, while others reported 
use in the past year
11,20,21,57,58
, or even more current use
20,22,24
. The lifetime prevalence of 
sedative and sleeping pill use measured in our study varied compared to previous 
studies
19,-24,57




medications being investigated. For example, some studies explored sleeping pills and 
sedative separately
19,57
, while some only examined benzodiazepines
20,21
.  
When compared to studies that used similar reference periods for consumption, 
my findings on the non-medical use of sedative and sleeping pills agree with previous 
research. Specifically, a survey of Canadian university students reported 2.1% of 
respondents reported past year non-medical sedative use
1
.  Similarly, an American study 
reported that 2.3% and 3% of students reported using non-prescription sleeping 
medications and anxiety medications respectively
19
 and a study from Ecuador reported 
that 3.9% of students report current non-medical use of sedatives
20
. The results of my 
thesis show slightly lower frequency of use among respondents than the only other 
previous study I found that examined frequency of sedative medication use
58
. However, 
the results of my thesis are agreeable with other studies that have found monthly or 
weekly use is more common than daily, or more frequent use
23,58
.  
Generally, my results agree with previous finding of prevalent mental illness or 
symptoms on university campuses
1-4,59
. However, the reported prevalence of symptoms 
of depression, anxiety, and stress are difficult to compare to other studies because most 
studies used different measurement methods and investigated different populations. Some 
studies asked about past diagnosis of mental illnesses
2
, whereas other used different tools 
to assess symptoms or experiences of mental health issues
3-5,59
. However, previous 
studies that used the DASS (either the 21 or 42 item versions) reported similar results.  
For example, the study by Baryam et al.
60
 reported that similar prevalence of moderate to 
extremely severe symptoms of depression (27%), anxiety (47%), and stress (27%) in a 
sample of Turkish university students. My results are also comparable to those found by 
Beiter et al.
61
, who reported moderate to extremely severe symptoms of depression (23%) 
and stress (26%) in a sample of American university students. Even when comparing to 
similar studies there are concerns over methodology and the reliability of their results.  
 
3.7.2.3 Associations between non-medical sedative and sleeping pill use and depression 
My results that non-medical use of sedative and sleeping pill is not associated 
with moderate to extremely severe symptoms of depression, anxiety, and stress does not 




medical use of prescription medications, such as opioids, stimulants, and sedatives, report 
higher symptoms of mental health issues
11,24,57,58
. Many of these studies, however, 
examine groups of prescription medications together and do not assess sedatives 
independently. In fact, I found only one study that explored the association between 
sedative use and depression
11
 and that study found that students reporting sedative use 
were more likely to report feelings of depression.  
The differences in results may be due to differences in methodology between my 
study and previous studies. Specifically, Zullig et al.
11
 relied on data from the 2008 
American ACHA survey. This survey assessed the past year non-medical use of sedatives 
and defined non-medical use as only including taking medications “not prescribed to 
you.” In contrast, my study asked about more recent non-medical sedative use defined as 
off label use or taking medications that are not prescribed to you. It is likely that the 
ASSIST is a more valid measure of non-prescription medication use which may have 
reduced measurement bias. Differences in findings may also be a function of the 
instruments used to assess mental health. My study uses the DASS 21 to assess 
symptoms of depression, anxiety, and stress, whereas Zullig et al.
11
 asks about feelings of 
depression. 
 
3.7.2.4 Associations between non-medical sedative and sleeping pill use and anxiety, 
stress 
I did not find previous studies that examined the association between non-medical 
use of sedative and sleeping pills and symptoms of stress or anxiety in university 
students. However, the results of the current study are not surprising because sedatives 
are commonly prescribed for anxiety and sleep difficulties. They are CNS depressants 
that are designed to induce a calming effect. So it may be that those using sedatives, 
whether prescribed or not, will experience fewer symptoms of mental health issues 
because that is the intended effect of those medications. Therefore, it is possible that 
students engage in self-medication. Another possible reason for the lack of associations 
between non-medical sedative and sleeping pill use and mental health may be the low 
reported frequency of use. I showed that although 3.7% of students reported use in the 




frequency of use of other substances (marijuana and alcohol use) is a predictor of mental 
health, it is possible that the lack of association is due to low frequency if use
12,62-64
. 
 It is important to note that there was a significant crude negative association 
between non-medical use of sedatives and sleeping pills and moderate to extremely 
severe symptoms of stress. This relationship remained negative, but was no longer 
significant once covariates were controlled for. This change could be due to a low sample 
size or due to the effect of the covariates “marijuana use in the past 3 months”, “past 
week neck pain”, and “diagnosis of a mood disorder” on the variables of interest. For 
example, marijuana use in the past 3 months could contribute to the relationship between 
sedative and sleeping pill use and symptoms of stress through the finding that 
polysubstance use is common in those who report the non-medical use of prescription 
medications, and those who experience mental health issues may self-medicate
13-15,65
. 
Neck pain may also be related to sedative and sleeping pill use through self-medication, 
and may be related to stress through pains connection to poor mental health. Finally, the 
covariate mood disorder may be related to stress through patterns of comorbidity, and 
may be related to sedative and sleeping pill use through self-medication.  
 
3.7.3 Strengths 
 My study has several strengths.  First, I was able to assess the representativeness 
of our sample by comparing study participants to students enrolled in each faculty. The 
analysis suggests that our sample is representative of our population with regards to 
gender, year of study, and residency status. Second, I measured my dependent variable, 
independent variable, and covariates using standardized and psychometrically sound 
questions and instruments, which minimize measurement bias. Third, data was collected 
online which minimized biases related data transfer, coding, and completeness. Finally, I 
measured and used a wide range of covariates to test the independence of the association 
in my regression models.  
 
3.7.4 Limitations 
 My study also had limitations. First a potential limitation of the study is social 




possible students did not answer honestly. Second, participation rate for this study was 
40%. Although higher than previous similar studies, this could have resulted in our 
sample not capturing a true range of mental health and sedative use behaviours; biasing 
the results. For example, only capturing healthy students, or only capturing those with 
experience with mental health issues. Finally, we studied students enrolled in two of the 
faculties at our university and therefore, my results may not be generalizable to other 
faculties or universities.  
 
3.7.5 Future Directions 
A cohort study is needed to understand whether non-medical sedative use is a risk 
factor for poor mental health in university students. Qualitative research may also be 
helpful to understand students’ experiences with substance use and mental health. Future 
research should also assess the motivations for substance use and investigate other mental 
health disorders and substances. For example, opioids are a significant public health 







My thesis is the first to investigate the association between the non-medical use of 
sedatives and sleeping pills and symptoms of mental health in Canadian University 
students. I reported on the lifetime and past 3 month prevalence of non-medical sedative 
and sleeping pill use and past week symptoms of depression, anxiety, and stress. I was 
also able to examine the association between the non-medical use of sedative and 
sleeping pills and student mental health. The results suggest that the non-medical use of 
sedatives and sleeping pills is not associated with symptoms of moderate to extremely 
severe symptoms of depression, anxiety, and stress in undergraduate students. However, 
my findings do not allow me to determine whether non-medical sedative and sleeping pill 
use is a risk factor for mental health because of the cross-sectional nature of the study.  
My thesis demonstrates that poor mental health presents a significant issue on the 
UOIT campus and that some students are engaging in the non-medical use of sedative 




student health. Future research is needed to better understand student mental health and 
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Table 1. Comparison of faculty of health sciences and faculty of education population 
with study sample. 












Age 24 22.1  28 25.6  
Gender 75.9% F 79.9% F  66.7% F 68.1% F  
Year of 
Study: 
  Year 1 
  Year 2 
  Year 3 
  Year 4 



























































Table 2. Characteristics of students enrolled in the faculty of health sciences and the 
faculty of education. 









Age (Mean; SD) 22.1 (SD:5.5) 25.6 (SD:4.8) 22.98 (SD:5.5) 
Gender 
  Female 
  Make 
  Female to Male 
  Male to Female 
  Queer 
  Do Not Disclose 


























  Nursing 
  Kinesiology 
  Public Health 
  HH 
  MedLab 
  Allied Health 
  Health  
  Sciences Comprehensive 
  Fitness 
  Nursing Bridge 

























Year of Study 
  1 
  2 
  3 
  4 
























 Physical Activity 
 Excellent 




 Muscle Strength 
 Excellent 




 Perceived Fitness 
 Excellent 























































































  Depression 
  Anxiety 













WHO DQ (3-5)   
  Depression 
  Anxiety 
  Stress 
















PSQI (poor sleep) 63.6% 64.7% 63.8% 
Food Security 
  Secure 
  Moderate 
  Moderate 




















Neck Pain (rating) 3.5 (SD: 2.5) 3.1 (SD: 2.4) 3.4 (SD: 2.5) 
Back Pain (yes) 67.4% 60.9% 65.9% 
Back Pain (rating) 3.8 (SD: 2.7) 3.6 (SD: 2.8) 3.7 (SD: 2.7) 
ASSIST-Tobacco life 33.5% 42% 35.5% 
ASSIST-Tobacco 3 month 14.1% 20.8% 15.6% 
ASSIST-Alcohol life 78.2% 86% 80% 
ASSIST-Alcohol 3 month 72.3% 82.1% 74.6% 
ASSIST-Marijuana life 44.1% 51.2% 45.8% 
ASSIST-Marijuana 3 month 24% 28.5% 25.2% 
ASSIST-Cocaine life 5.2% 7.7% 5.8% 
ASSIST-Cocaine 3 month 1.5% 2.4% 1.7% 
ASSIST-Stimulants life 9.2% 9.7% 9.3% 
ASSIST-Stimulants 3 month 4% 3.9% 4% 
ASSIST-Inhalant life 0.9% 2.9% 1.4% 
ASSIST-Inhalant 3 month 0.4% 0.5% 0.5% 
ASSIST-Sedative life 7.4% 9.2% 7.8% 
ASSIST-Sedative 3 month 3.4% 4.8% 3.7% 
ASSIST-Hallucinogen life 5.9% 8.7% 6.6% 
ASSIST-Hallucinogen 3 month 1.3% 1.4% 1.4% 
ASSIST-Opioid life 2.7% 2.4% 2.6% 
ASSIST-Opioid 3 month 0.1% 0.5% 0.2% 
ASSIST-Injection 
(yes, but not in past 3 months) 
0.3% 0.5% 0.3% 
Student Life 1 
(sometimes and always) 
95.4% 93.7% 95% 
Student Life 2 (sometimes and 
always) 




Student Life 3 (agree and strongly 
agree) 
89.5% 89.9% 89.6% 
Student Life 4 (agree and strongly 
agree) 
17.6% 15.9% 17.2% 
Marital Status 
  Single 
  Married 
  Separated 

















  0 
  1 













Academic Average in the Last Year 
  A 
  B 
  C 
















Annual Personal Income 
  0-4999 
  5-9999 
  10-19999 

















  0-49999 
  50-59999 
  60-79999 
















Hours of work a week 
  0 
  1-9 
  10-19 
  20-29 
  30-39 


























  Relatives 
  Non Relatives 
  Residence 
  Alone 




















  Less than 15 min 










Citizenship (Canadian) 79.6% 83.6% 80.5% 
Residency (domestic) 98.4% 99.5% 98.6% 
Ethnicity 
  Aboriginal 
  Black 













Parents Marital Status 
  Single 
  Married 
  Divorced 


















  Fulltime 















  Fulltime 


























Table 3. Crude association between non-medical sedative and sleeping pill use in the past 
3 months and symptoms of depression, anxiety, and stress in the past week. 









































































Table 5. Bivariate associations between non-medical sedative and sleeping pill use in the 




Depression OR (95% 
CI) 
Anxiety OR (95% CI) Stress OR (95% CI) 
PSQI 1.302 (0.577-2.938)* 0.679 (0.324-1.424) 0.391 (0.185-0.827) 
Medical 
Cond 
1.256 (0.574-2.753)*+ 0.718 (0.353-1.459)*+ 0.439 (0.316-0.891)*+ 
Mood Dis NA 0.866 (0.411-1.823)* 0.577 (0.257-1.203)* 
Caucasian 1.128 (0.516-2.465)*+ 0.635 (0.314-1.285) 0.401 (0.198-0.810) 
Black 1.165 (5.34-2.542) 0.649 (0.321-1.312) 0.392 (0.194-0.791) 
HFSD 1.186 (0.538-2.613)*+ 0.653 (0.320-1.334) 0.397 (0.195-0.808) 
Sedentary 
Behaviour 
1.132 (0.517-2.475)* 0.631 (0.311-1.279) 0.377 (0.185-0.766) 
Physical 
Activity 
1.157 (0.529-2.529) 0.657 (0.324-1.331) 0.398 (0.197-0.804) 
Age 1.091 (0.498-2.390)* 0.615 (0.303-1.247)* 0.384 (0.190-0.777) 
Gender 1.224 (0.554-2.703)* 0.655 (0.324-1.327) 0.400 (0.197-0.810) 
Alcohol 1.131 (0.517-2.472)* 0.659 (0.326-1.334) 0.399 (0.197-0.807) 
Marijuana 1.303 (0.591-2.871)* 0.714 (0.350-1.455)* 0.439 (0.215-0.896)* 
Cocaine 1.122 (0.512-2.460)*+ 0.631 (0.310-1.283) 0.410 (0.202-0.834) 
Stimulant 1.360 (0.600-3.080)*+ 0.786 (0.377-1.637)* 0.416 (0.200-0.867) 
Neck Pain 1.254 (0.572-2.747)* 0.727 (0.355-1.487)* 0.440 (0.214-0.905)* 
Back Pain 1.244 (0.568-2.723)*+ 0.718 (0.351-1.467)* 0.423 (0.208-0.861) 
Average 1.176 (0.537-2.578) 0.648 (0.320-1.310) 0.394 (0.195-0.796) 
Marital 
Status 
1.150 (0.526-2.514) 0.643 (0.318-1.302) 0.392 (0.194-0.792) 
Annual 
Income 
1.089 (0.495-2.396)* 0.664 (0.325-1.355) 0.369 (0.181-0.752) 
Year of 
Study 
1.160 (0.530-2.535) 0.644 (0.318-1.305) 0.390 (0.192-0.791) 
Canadian 
Citizenship 
1.178 (0.539-2.572) 0.654 (0.323-1.323) 0.420 (0.207-0.852) 
Household 
Income 
1.131 (0.515-2.484)* 0.648 (0.320-1.312) 0.391 (0.193-0.791) 
*Bivariate models that resulted in a more than 10% change in the Beta for past 3 month 
sedative use. 
+Covariates that were removed from the adjusted model because their significance level 









































4.1 THESIS SUMMARY 
 Through the implementation of the UOIT Mental Health and Wellness Study, I 
explored the association between the non-medical sedative and sleeping pill use and 
moderate to extremely severe symptoms of depression, anxiety, and stress in 
undergraduate university students in two faculties at the UOIT. My study is one of the 
first epidemiological examinations of this association in university students and my 
research was informed by the available peer-reviewed literature and a pilot study 
conducted in the target population at UOIT. 
 
4.1.1 Pilot Study 
 We conducted a pilot study to determine the feasibility of completing a cross-
sectional study of mental health in undergraduate students. We developed a survey 
instrument that included valid and reliable tools and questions to measure student mental 
health and identify potentially modifiable risk factors. The pilot study confirmed that 
studying mental health at UOIT was feasible and that the survey instrument was clear, 
acceptable in length and adequate for in-class administration. The data collected during 
the pilot study also confirmed that students were comfortable with answering sensitive 
questions about their mental health and substance use. Finally, it confirmed that it was 
feasible to study the association between non-medical sedative and sleeping pill use and 
symptoms of depression, anxiety, and stress. 
 
4.1.2 Cross-sectional Study 
The general objectives of the cross-sectional study were to examine the 
association between student mental health, sociodemographic variables, comorbidities 
and lifestyle factors. The specific objectives of my thesis were to: 1) measure the lifetime 
and past 3-month prevalence of non-medical sedative and sleeping pill use; 2) measure 
the one-week prevalence of moderate to extremely severe symptoms of depression, 
anxiety, and stress; and 3) measure the association between the non-medical use of 
sedative and sleeping pills, and moderate to extremely severe symptoms of depression, 




The results of my thesis advance the knowledge in this field because previous 
studies on the association between sedative use and mental health in university students 
have important methodological limitations. First, the definition of “sedatives” and “non-
medical use” was not standardized in several studies
1-4
. Second, it is not clear whether 
previous studies used valid and reliable methods to measure mental health issues
1-3,5-7.
 
For example, some studies ask about motivations for use
2,6,7
, while others asked about 
symptoms or presence of mental health issues 
1,4
. In addition, many studies had low 
participation rates and were therefore liable to selection bias
1,2,7,8
. Finally, studies in this 
field do not adequately control covariates when measuring the association between non-
medical sedative and sleeping pill use and symptoms of depression, anxiety, and 
stress
1,2,6
. Overall, these issues likely introduced bias and reduced the validity of the 
available research. My thesis sought to address these methodological limitations by using 
psychometrically sounds assessments in the questionnaire and maximizing participation.  
I found that the lifetime and 3-month prevalence of non-medical sedative and 
sleeping pills use were 7.8% (95% CI [6.1, 9.8]) and  3.7% (95% CI [2.6, 5.2]) 
respectively, with 2.5% (95% CI [1.6, 3.8]) reporting using sedatives or sleeping pills 
once or twice in the past three months. The reported lifetime prevalence is within the 
range of previous studies
3,4,6-10




I also found that the one-week prevalence of moderate to extremely severe 
symptoms of depression, anxiety, and stress were 30.3% (95% CI [27.3, 33.4]), 47.3% 
(95% CI [43.9, 50.6]), and 25.5% 95% CI [22.7, 28.5]) respectively. My estimates of the 
prevalence of mental health symptoms are similar to those of previous studies from 
Turkey and the United States that used the DASS 21
12,13
. However, my results may not 
be directly comparable to previous studies that use different measurement methods of 
mental health. Nevertheless, my results agree with the finding that mental health 
symptoms are common on university campuses
11,14-17
.  
My multivariable logistic regression analysis suggest that the use of non-medical 
sleeping pill and sedatives is not associated with moderately to extremely severe 
symptoms of depression, anxiety, or stress. These results disagree with previous research 
which found that sedative use was associated with feelings of depression
1




previous research suggests that some students report the non-medical use of sedatives to 
help cope with stress, anxiety, and depression 
6,7
. The differences in results may be 
explained by differences in the: 1) definition and measurement of sedative use and 2) 
definitions and measurement of mental health symptoms (for example self-reported 
diagnosis versus measurement with a valid and reliable tool).  
Conceptually, the lack of association between non-medical use of sleeping pills 
and sedative and moderately to extremely severe symptoms of depression, anxiety, or 
stress is not surprising because sedative medications are commonly prescribed for sleep 
and anxiety issues
18
. Therefore, participants who reported using sedative non-medically 
may report fewer symptoms of mental health because the medication is effective in 
reducing their symptoms. It may also be due to the low frequency of use in my study. 
Previous studies have noted that the frequency of use of a substance may be associated 





The one-week prevalence of symptoms of moderately to extremely severe 
symptoms of depression, anxiety, and stress in my sample of UOIT students is 
concerning for several reasons. First, it suggests that the student population struggles with 
significant symptoms of poor mental health. This is alarming because previous research 
has shown that students with poor mental health may not seek care or support for mental 
health
22-24
. This is also important because poor mental health is associated with poor 
academic outcomes, substance use, and suicide/self- harm
1,17,26-28
. 
Similar concerns can be noted when considering non-medical sedative and 
sleeping pill use. Although a relatively small number of students reported use in the past 
three months, the risks of use are still present for those students. Even though I found no 
association between non-medical sedative and sleeping pill use and symptoms of mental 
health, the use of sedative medications can lead to dependence, cognitive issues, health 
complications, early death, and overdose risk
29-34
. Therefore, the findings of my thesis 
cannot be used to validate the non-medical use of sleeping pills and sedatives without a 




of the associated health risks, and universities should consider developing plans to 
address this issue on their campuses.  
When considering an intervention for substance use in this population, the initial 
thought may be to encourage students not to use substances. However, prohibition or 
encouraging someone not to use a substance may not effectively reduce use
35
. The 
concept of prohibition ignores the idea that not all use is problematic. For example, in a 
study conducted by Holloway et al.
2
 only 10% of those reporting non-medical medication 
use reported experiencing a negative consequence. In a study by Boyd et al.
36
 of sedative 
misuse in the general population, it was revealed that few individuals that misused 
sedative went on to develop a substance use problem. Moreover, it is the frequency of use 
that may play a role in the development of poor mental health. In a study by McCabe et 
al.
20
 more frequent use of stimulant medication was associated with higher scores on a 
measure of problematic substance use. This finding is echoed by other studies examining 
stimulant use and marijuana use
19,21
. Therefore, encouraging students to avoid using may 
discourage an open dialogue about substance use. Instead, a well-informed harm 
reduction approach that focuses on education and policy changes at the university level 
may be more beneficial to students.  
Harm reduction is a drug intervention approach that strives to reduce the risks 
associated with use, without calling for abstinence
37
. It acknowledges that individuals 
may not be able or willing to stop their substance use, but that risks associated with use 
can be reduced to improve outcomes for users. Some well-known examples of harm 
reduction include safe injection sites, needle exchanges, and providing clean drug kits
38
. 
However, the implementation of harm reduction programs is challenging. Specifically, 
the difficulty with employing a harm reduction approach is the lack of formal processes 
and stigma
39,40
. Harm reduction is one of the pillars of Canadas’ drug strategy, however a 
recent review of policies and frameworks revealed that few provinces have a formal 
strategy for this type of intervention
39,41
. Harm reduction, although a specific practice 
could be accepted as a philosophy for care at universities and integrated into student 
education and policy changes.  
Harm reduction strategies have been used by universities to address substance use 
on campuses
42-45
. In reviews by Marlatt et al.
44
 and Neighbors et al.
45




strategies to address harmful alcohol consumption on campuses were discussed. The 
authors reported that programs that utilize a harm reduction approach to minimize 
harmful drinking in university students have reduced drinking related harms and 
consequences. These studies point to programs that focus on educating students around 
the harms of alcohol use, safe drinking practices, as well as motivational interviewing 
skills to help with self-reflection regarding personal alcohol use.  
Harm reduction research involving the non-medical use of medications is less 
common than research exploring alcohol or illicit drug use. Nevertheless, 
recommendations have been developed for education and policy on reducing non-medical 
prescription medication use in university students; many of which embrace a harm 
reduction philosophy. For example, Arria et al.
46
 recommended education and policy 
changes to address stimulant use on university campuses, and state that their 
recommendations could be applied to other medications. They suggest providing 
information to students about the risks of use by highlighting research findings and real-
life consequences of use. Moreover, the authors recommend encouraging students to 
discuss use and its potential harms to destigmatize the topic and creating an atmosphere 
where students can talk about use. The authors also make recommendations for university 
policy. These include encouraging campus doctors to be aware of substance use patterns 
in the community and prescribe medications cautiously, as well as the creation of 
university actions plans to reduce use. In their study, Holloway et al.
47
 recommended that 
universities should understand drug use patterns in their own community by searching 
trends online, and provide up-to-date and accurate information to students about the 
harms of use. Other studies have recommended early assessment of mental health and 




The above studies make general recommendations that could be applied to the 
non-medical use of any medication. When applied to the non-medical use of sedatives, 
education could involve the risk of specific harms (such as overdose risks when mixed 
with other nervous system depressants and cognitive decline) associated with misusing 
sedatives. Students may be particularly interested in, and unaware of, the negative impact 




report the non-medical use of stimulants as a means to increase their academic 
performance, but the actual benefits are understated and do not outweigh the risks of 
use
50
. Education strategies could also address the underlying reasons for use (ie. to cope 
with mental health symptoms) by providing information about improving coping skills, 
resiliency, organizational/academic skills, and on campus mental health and substance 
use supports.  
Students will likely continue to use prescription sedatives non-medically, and 
although not all will develop an issue as a result of their substance use, the risks 
associated with non-medical use are substantial. Research about the non-medical use of 
sedatives should be used to inform university policies and education directed at students, 
with the aim of reducing the risks associated with use.  
 
4.3 STRENGTHS 
 The primary strength of the study is the use of valid and reliable assessment tools 
to measure constructs. We also included a wide range of covariates to be used in our 
models. Another key strength was the recruitment strategy and data collection methods. 
The study design allowed for consistent data collection that minimized data transcription 
and transfer errors. Finally, my sample was also representative of the student population 
enrolled in the two faculties. 
 
4.4 LIMITATIONS 
 The first limitation of my thesis relates to selection bias.  The overall participation 
rate was 40%. Although our sample was representative of the population of students 
enrolled in the two faculties, it is nevertheless possible that they differ on factors related 
to mental health and sedative use.  Second, it is possible that the measurement of 
sedatives, sleeping pills and mental health were influenced by social desirability bias. 
Due to the nature of the survey, students may not have been comfortable providing 
answers; resulting in an underestimation of mental health and substance use. Finally, my 






4.5 FUTURE DIRECTIONS 
My thesis focused on the one-week prevalence of moderate to extremely severe 
symptoms of depression, anxiety, and stress. Future research should investigate other 
mental health issues and illnesses, such as specific anxiety and mood disorders, 
psychosis, and substance dependence. Late teenage years to early 20s are a common time 
for the development of mental health symptoms and illnesses
51,52
. Therefore, the 
assessment of other mental health issues or illnesses is needed to get a fuller picture of 
mental health on university campuses. Motivations for substance use are also an 
important area to study. Reasons for use are a key consideration when developing and 
implementing a prevention program. For example, if students are reporting substance use 
to cope with mental health, then an intervention aimed at addressing underlying mental 
health issues and teaching coping skills may be more effective. On the other hand, if 
students use sedatives to cope with the demands of the academic programs, then 
interventions focused on developing healthy academic skills and dispelling the myths 
associated with use (ie. substances may hinder cognitive abilities not improve them) may 
be needed. Motivations for non-medical sedative use could be explored through 
questionnaires or qualitative studies that inquire about reasons for substance use. Finally, 
a cohort study to determine whether non-medical sedative and sleeping pill use is 
associated with mental health problems is needed to understand the etiology of 
depression, anxiety and stress in university students.  
 
4.6 CONCLUSIONS 
Mental health is a public health concern in Canada. University students are a 
particularly vulnerable population when it comes to mental health and its impact. My 
professional and personal experiences with mental health have highlighted to me the 
challenges that youth face when experiencing the pressures of school and personal life 
while separated from their support networks. I am also aware through my various 
experiences that the non-medical use of sedatives does occur. I have been told by 
individuals using sedatives non-medically that they have done so for a variety of reasons, 




My thesis found that symptoms of depression, anxiety, and stress are prevalent in 
the faculty’s surveys, and a small number of students are engaging in the non-medical use 
of sedative and sleeping pills. I did not find an association between sedative use and 
mental health. This may be due to the fact that sedative and sleeping pills use may not 
impact mental health at the levels being reported by students in my study, or because use 
of these medications reduces mental health symptoms. This information provides 
necessary background information to further explore mental health and sedative use on 
university campuses. Cohort and qualitative studies that assess the link between sedative 
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Initial search results 2684 
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missing/unavailable articles. 
 


































Appendix D  
In-Class Script (MHWS): Professor 
 
In class introduction script (for professors) 
 
Good Morning/Afternoon. Hoping you read the email sent out to you regarding 
exciting research university student mental health and wellness supervised by Dr. 
Pierre Côté and Graduate students here at CMCC (& UOIT).  Please welcome 
members of the research team here to conduct the pilot administration of the 

























Good Morning/Afternoon. My name is Michael Short/Nayantara Hattangadi/Andrew 
Reynolds. I am a Graduate student in the Faculty of Health Sciences. My thesis 
supervisor is Dr. Pierre Côté and I am studying mental health and wellness in 
undergraduate students. Therefore, we are conducting an online survey to better 
understand mental health and wellness in undergraduate university students.  
 
In order to conduct the study at the university, we need to understand if it is adequate 
and acceptable to you. We have spoken with your professors about testing the 
questionnaire in your class and they have agreed. The study is also supported by the 
Dean, of your Faculty. 
 
Your participation in this study is completely voluntary.  You will be asked to read 
an informed form that explains the study and what is required form you. The consent 
form also outlines the risks and benefits of participating in the study. If you agree to 
participate, we will ask you to complete the questionnaire today in class. Students 
who start to complete the questionnaire can drop out at any time if they wish to 
however, once the questionnaire has been submitted, the information will be 
maintained for data analysis. If you do not wish to participate in this study, you may 
quietly remain in the classroom. 
 
You will be required to use your UOIT.net login to access the questionnaire. Your 
UOIT.net user name and/or student ID number will be deleted from the data set prior 
to Dr. Côté receiving the data.  This will ensure that that your confidentiality and 
anonymity are maintained. All of the data will be stored on a secure network, which 





Creating an Announcement on Blackboard 
 
Announcements appear in the order you post them. The most recent announcement 
appears first. 
 



































3. Type a Subject, which appears as the title on the Announcements page. 






5. In the Web Announcements Options section, choose to restrict the announcement 
by date or not. 
● If you choose Not Date Restricted, the announcement is visible until you remove 
it. 
● If you choose Date Restricted, select the Display After and Display Until check 






6. Select the Email Announcement check box to send students an email containing 




receive announcement notifications through email. Your institution controls if this 
option is available. 
 
7. Optionally, in the Course Link section, select Browse to link to a course area, 
tool, or item. 
Links to course content won't appear in the email announcement if you choose to send 
one. 















UOIT Mental Health and Wellness Study 
 
Thank you very much for your willingness to participate in this survey. Your answers to 
the questionnaire will remain confidential. Once completed and submitted, the 
researchers will not be able to trace your answers back to you. If you agree to participate 
please check the box which is located at the bottom of the informed consent form. 
 
The purpose of this study is to assess the test feasibility of a conducting a large study to 
describe the burden and lifestyle factors associated with mental health and wellness in 
undergraduate university students. 
This questionnaire inquires about mental health and wellness and factors that may be 
related to it. These factors include sleep quality, physical activity, food access, neck and 
back pain, substance use and 
socio-demographic variables. 
 
You must be 18 years or older to participate in this study. 
 
We would like to remind you that if you are concerned about your well-being, or feel 
that, you may benefit from support and assistance, please contact Student Mental Health 
Services to set up an appointment. You can contact student services in one of three ways: 
- email studentlifeline@uoit.ca 
- call 905.721.3392 
- drop by Student Life suite (U5 Building at North Campus or 2nd floor of 61 
Charles St for the downtown campus) for a chat. 
There are also community resources available 24/7, they are: Distress Centre Durham at 
905-430-2522 and Durham Crisis Line at 905-666-0483 
Thank you very much for considering participating in this important study which will 






Title of Research Study: 
UOIT-CMCC Mental Health and Wellness study 
 
Researcher(s): 
Dr. Pierre Côté, Dr. Victoria Smye, Dr. Robert Weaver, Dr. Efrosini Papaconstantinou, 
Dr. Jennifer Laffier, Dr. Ellen Vogel, Dr. Tyler Frederick, and Dr. Cindy Malachowski, 
Kathy Smith, MHSc, Nayantara Hattangadi , Andrew Reynolds, Michael Short and 
Nancy Flynn 
Faculty of Health Sciences, 






You are invited to participate in a research study at the University of Ontario Institute of 
Technology in the Faculty of Health Sciences and Faculty of Education. This study (REB 
File # 17-xxxx) has been reviewed by the University of Ontario Institute of Technology 
Research Ethics Board and has been approved as of Month day 2017 Please read this 
form carefully, and feel free to ask any questions you might have. If you have any 
questions about your rights as a participant in this study, please contact the Ethics and 
Compliance Officer at 905 721 8668 ext 3693 or compliance@uoit.ca. 
 
Before agreeing to participate in this study, it is important that you read and understand 
the following explanation of the proposed study procedures. The following information 
describes the purpose, procedures, benefits, and risks associated with this study. It also 
describes your right to refuse to participate or withdraw from the study at any time. In 
order to decide whether you wish to participate in this research study, you should 
understand enough about its risks and benefits to be able to make an informed decision. 
This is known as the informed consent process. 
 
Please read through this document carefully, and ask Kathy Smith or Dr. Pierre Côté to 
explain anything that you don’t understand before consenting to this study. Make sure all 
your questions have been answered to your satisfaction before signing this document. 
 
Purpose and Procedure: 
The purpose of this study is to enhance our understanding of lifestyle factors that may be 
associated with mental health issues and help identify students who may be at risk of 
developing mental health problems. This information is necessary to mitigate the 
disabling effects of mental health problems. 
 
The mental health and well being in university students is a public health concern in 
Canada. However, we know very little about the prevalence of depressive symptoms, 
anxiety and stress among undergraduate university students. Therefore, we need to 
investigate these issues to better prevent and manage mental health problems in 
university students. 
 
We would appreciate if you could work with us in gaining knowledge about mental 
health and wellness in undergraduate students by consenting to participate in this study 
and completing an online questionnaire. You will complete this questionnaire once 
during the class time. The questionnaire will take approximately 15 minutes to complete, 
and all information provided is confidential. 
 
Time commitment: 
The questionnaire is a one-time, only, administration and will take approximately 15 
minutes to complete. The one-time administration will be in-class first. However if you 
are not able to participate in class there will be two follow emails sent that will provide a 






There are no direct benefits for participating in the study. However, participating will 
provide indirect benefits to the student community by reducing stigma and improving 
awareness of mental health and wellness. 
 
Potential Risk or Discomforts: 
There are no known risks associated with participating in the study. However, 
participants may experience psychological or emotional discomfort. We remind you that 
UOIT students who needs support or help should feel free to contact UOIT Student 
Mental Health services at the Student life suite. 
 
We’re here to support you! UOIT offers a range of services for students to support their 
positive mental health, strengthen their resilience, and help them manage the multiple 
demands of university life. If you are concerned about your well-being, or feel that, you 
may benefit from support and assistance, please contact Student Mental Health Services 
to set up an appointment. You can email (studentlifeline@uoit.ca), call 905.721.3392 or 
drop by Student Life suite (U5 Building at North Campus or 2nd floor of 61 Charles St 
for the downtown campus). 
 
For more information, and to learn about the services offered please visit the Student 
Mental Health website: http://studentlife.uoit.ca/mentalhealth/index.php 
 
Informed Consent (Continued) 
 
Storage of Data: 
All data and consent forms will be kept on a secure UOIT network, which the UOIT IT 
Department has assisted with. The IT department at UOIT will have access to the raw 
data and will remove and destroy all identifiers (Banner ID, UOIT.net login and date of 
birth). This data will be stored on a secure Google Drive account. Dr. Pierre Côté, Dr. 
Efrosini Papaconstantinou, Ms. Kathy Smith, Ms. Nayantara Hattangadi, Mr. Andrew 
Reynolds, Mr. Michael Short and Ms Nancy Flynn will have access to the de-identified 
amalgamated data but not to the raw data. 
 
Confidentiality: 
You will be using your UOIT.net account to login and answer the questionnaire. Once the 
data is collected, the UOIT net administration will take the data from the first 
administration of the questionnaire and assign a Study ID. The Study ID will bear no 
resemblance to any of your personal identifiers. The Study ID will maintain your 
anonymity. The UOIT net administration will then send a study data file without 
identifiers to Dr. Pierre Côté; the IT department will also destroy any original data files 
with identifiers once the study data file has been sent to Dr. Pierre Côté. Data files will be 
stored within UOITs Google Drive Suite for Education instance, which is hosted by 
Google. 
Anonymity: 
The raw data will be de-identified of any Banner ID or UOIT.net login information and 
replaced with a Study ID. The de-identified files will be sent to the research team to 




have information relating to personal identifiers so the release of these findings will be 
completely anonymous. 
 
Right to Withdraw: 
Your participation in this study is completely voluntary and will not affect your standing 
within this course. You are free to withdraw at any point in time. If you do not wish to 
take part in the study, you do not need to complete the consent form and may remain 
seated in the class. If you wish to withdraw after giving informed consent but before 
submitting the questionnaire, you may do so by leaving the webpage where the 
questionnaire is available. This data will not be recorded. 
 
You can also withdraw at anytime before November 15, 2017 by contacting Neil Hopkins 
or Bevin Moolenschot from the UOIT IT Department by emailing Ask@uoit.net. They 
will delete your data and you information will be used in the analysis. 
 
Compensation for Participation: 
There will be no compensation to participants for involvement with this study. 
 
Debriefing and Dissemination of Results: 
The results of this study will be completed by December 2017. If you desire to receive 
information regarding the results of this study, please contact the researchers at (905) 
721-8668 Ext 5922 or by email at kathy.smith@uoit.ca or pierre.cote@uoit.ca. You will 
also be invited to a debriefing session were the results of the study will be presented to 
participants. 
 
Participant Concerns and Reporting: 
This research project has been approved by the University of Ontario Institute of 
Technology Research Ethics Board (REB File # 17-xxxxx) as of Month day 2017. 
 
If you have any questions concerning the research study, or experience any discomfort 
related to the study please contact the researcher(s) at (905) 721-8668 Ext 5922 or by 
email at kathy.smith@uoit.ca or pierre.cote@uoit.ca. 
 
Any questions regarding your rights as a participant, complaints or adverse events may be 
addressed to Research Ethics Coordinator at researchethics@uoit.ca or (905) 721 8668 
ext 3693. 
 
1. Informed Consent * Check all that apply. 
I consent to voluntarily take part in the study with the understanding I may withdraw at 
any time. I have had an opportunity to ask questions and my questions have been 
answered. I am aware of all the risks and benefits associated with my participation and 
have read the entire consent form. I am free to ask questions about the study in the future. 
 
2. Secondary Use of Data 
The information collected for this study may be used for secondary research in the future. 




Check all that apply. 
 
I agree to allow the data collected in the study to be used for future secondary research 
 
Ready to begin 
Thank you for participating in the University of Ontario Institute of Technology Student 
Mental Health and Wellness study. Your answers will remain completely confidential. 
Once completed and submitted, the researchers will not be able to trace your answers 
back to you. The questionnaire includes questions regarding lifestyle behaviours (sleep 
habits, physical activity, alcohol and drug use, food access, socio- demographic variables, 




3. How old are you? * 
















































4. What gender do you identify with? * 
Mark only one oval. 
Female 
Male 
Transgender Male/Trans Man/Female-to-Male (FTM) 
Transgender Female/Trans Woman/Male-to-Female (MTF) 
Genderqueer, neither exclusively male nor female (or Gender Fluid, or Non-
Binary Gender) 
Choose not to disclose 
Other: 
 
5. What is your program of study? * 





Medical Laboratory Science 
Allied Health Science 
Health Science Comprehensive 
Fitness and Health Promotion Bridge 
Nursing (Registered Practical Nurse Bridge) 
Other: 
 
6. What is your year of study? * 










7. Have you been diagnosed with any of the following medical conditions by a healthcare 
provider? 
Please check all that may apply 
Check all that apply. 
Allergies (including hay fever or nasal allergy) 




Attention disorder or learning disability (e.g., attention deficit disorder, attention 
deficit 
hyperactivity disorder, learning disability) 
Bowel disorder such as Crohn's Disease, ulcerative colitis, Irritable Bowel 
Syndrome or bowel 
incontinence 
Chronic fatigue syndrome 
Eating disorder (e.g., anorexia nervosa, bulimia nervosa) 
High blood pressure 
Intestinal or stomach ulcers 
Migraine headaches 
Mood disorder such as depression, bipolar disorder, mania or dysthymia 
Scoliosis 
Sexually transmitted infection(s) 
Other: 
 
About your physical activity in the past 7 days 
 
Please answer the following questions based on what you do in a typical week. To 
increase accuracy, you may wish to think about your physical activity and sedentary 
behaviour for one week prior to answering the questions. 
 
Aerobic Physical Activity 
 
8. In a typical week, how many days do you do moderate-intensity (like brisk walking) to 
vigorous-intensity (like running) aerobic physical activity ? * 









9. On average for days that you do at least moderate-intensity aerobic physical activity 





Please answer the following questions based on what you do in a typical week. To 
increase accuracy, you may wish to think about your physical activity and sedentary 
behaviour for one week prior to answering the questions. 
 
Muscle Strengthening Physical Activity 
 
10. In a typical week, how many times do you do muscle strengthening activities (such as 
resistance training or very heavy gardening)?  
 
Please answer the following questions based on what you do in a typical week. To 
increase accuracy, you may wish to think about your physical activity and sedentary 
behaviour for one week prior to answering the questions. 
Perceived Aerobic Fitness 
 
11. In general, would you say that your aerobic fitness (ability to walk/run distances) is: * 







Please answer the following questions based on what you do in a typical week. To 
increase accuracy, you may wish to think about your physical activity and sedentary 




12. On a typical day, how many hours do you spend in continuous sitting: at work, in 
meetings, volunteer commitments and commuting (i.e., by motorized transport)? * 
Mark only one oval. 
None 
less than 1 hour 
1 to less than 2 hours 
2 to less than 3 hours 
3 to less than 4 hours 
4 to less than 5 hours 
5 to less than 6 hours 
more than 6 hours 
 
13. On a typical day, how many hours do you watch television, use a computer, read, and 
spend 
sitting quietly during your leisure time? * 





less than 1 hour 
1 to less than 2 hours 
2 to less than 3 hours 
3 to less than 4 hours 
4 to less than 5 hours 
5 to less than 6 hours 
more than 6 hours 
 
14. When sitting for prolonged periods (one hour or more), at what interval would you 
typically take a break to stand and move around for two minutes? * 
Mark only one oval. 
less than 10 minutes 
10 to less than 20 minutes 
20 to less than 30 minutes 
30 to less than 45 minutes 
45 to less than 1 hour 
1 to less than 1.5 hours 
1.5 to less than 2 hours 
more than 2 hours 
 
About your Mental Health 
 
Please read each statement and place a check beside the option which indicates how 
much the statement applied to you over the past week. There are no right or wrong 
answers. Do not spend too much time on any statement. 
The rating scale is as follows: 
- Never: Did not apply to me at all 
- Sometime: Applied to me to some degree, or some of the time 
- Often: Applied to me to a considerable degree, or a good part of time 
- Almost Always: Applied to me very much, or most of the time 
 
15. Your Mental Health * 
Check the one best response (below) regarding your mental health in the past week. 
Mark only one oval per row. 
Never/Sometimes/Often/Almost Always 
a) I found it hard to wind down 
b) I was aware of dryness of my mouth 
c) I couldn't seem to experience any positive feeling at all 
d) I experienced breathing difficulty (e.g. excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
e) I found it difficult to work up the initiative to do things 
f) I tended to over-react to situations 
g) I experienced trembling (e.g. in the hands) 





i) I was worried about situations in which I might panic and make a fool of 
myself 
j) I felt that I had nothing to look forward to 
k) I found myself getting agitated 
l) I found it difficult to relax 
m) I felt down-hearted and blue 
n) I was intolerant of anything that kept me from getting on with what I was 
doing 
o) I felt I was close to panic 
p) I was unable to become enthusiastic about anything 
q) I felt I wasn't worth much as a person 
r) I felt that I was rather touchy 
s) I was aware of the action of my heart in the absence of physical exertion 
(e.g. sense of heart rate increase, heart missing a beat) 
t) I felt scared without any good reason 
u) I felt that life was meaningless 
 
16. Please think about the last 30 days, taking both good and bad days into account. For 
each 
question, please tell me how much of a problem it is for you on a scale from 1 to 5. 1 
means 
no problem and 5 means extreme problem. * 
Mark only one oval per row. 
1/2/3/4/5/Don't Know 
a) How much of a problem do you have with feeling sad, low or depressed? 
b) How much of a problem do you have with feeling worried, nervous or 
anxious? 
c) How much of a problem is handling stress, such as controlling the 
important things in your life? 
d) How much of a problem is coping with all the things you have to do? 
 
About your Sleep 
 
The following questions relate to your usual sleep habits during the past month only. 
Your answers should indicate the most accurate reply for the majority of days and nights 
in the past month. Please answer all questions. 
 
17. During the past month when have you USUALLY gone to bed at night? * 
Please indicate the hour (Hrs) and minute (Mins) and ensure you have chosen AM or PM. 
Example: 8:30 AM 
 
18. During the past month, how long has it USUALLY taken you to fall asleep each 
night? * 
Mark only one oval. 
15 minutes or less 




31 - 60 minutes 
more than 60 minutes 
 
19. During the past month, when have you USUALLY gotten up in the morning? * 
Please indicate the hour (Hrs) and minute (Mins) and ensure you have chosen AM or PM. 
Example: 8:30 AM 
 
20. During the past month, how many HOURS of actual sleep did you get a night? (This 
may be different than the number of hours you spend in bed.) * 
Please indicate the number of hours (Hrs) and minutes (Mins). 
Mark only one oval. 
more than 7 hours sleep/night 
6 to 7 hours sleep/night 
5 to 6 hours sleep/night 
less than 5 hours sleep/night 
 
21. During the past month, how often have you had trouble sleeping because you... * 
For each of the remaining questions, check the one best response. 
Mark only one oval per row. 
Not during the past month/Less than once a week/Once or twice a 
week/Three or more times a week 
a) Cannot get to sleep within 30 minutes 
b) Wake up in the middle of the night or early morning 
c) Have to get up to use the bathroom 
d) Cannot breathe comfortably 
e) Cough or snore loudly 
f) Feel too cold 
g) Feel too hot 
h) Have bad dreams 
i) Have pain 
j) Other reason(s), please describe, including how often you have had trouble 
sleeping of this reason(s): 
 
22. If you have checked Other reason(s) above, please describe: 
 
23. During the past month... * 
For each of the remaining questions, check the one best response. 
Mark only one oval per row. 
Not during the past month/Less than once a week/Once or twice a 
week/Three or more times a week 
a) During the past month, how often have you taken medicine (prescribed or 
"over the counter") to help you sleep? 
b) During the past month, how often have you had trouble staying awake 
while driving, eating meals, or engaging in social activity? 
c) During the past month, how much of a problem has it been for you to keep 





24. During the past month, how would you rate your sleep quality overall? * 






About your access to Food 
 
These next questions (statements) are about the food eaten in your household in the last 
12 months, since March of last year and whether you were able to afford the food you 
need. Select the appropriate option from the choices listed below each statement 
depending on the number of persons in the household. 
 
25. "The food that (I/we) bought just didn’t last, and (I/we) didn’t have money to get 
more.” * Was that often, sometimes, or never true for (you/your household) in the last 12 
months? 




Don't know/refuse to answer 
 
26. “(I/we) couldn’t afford to eat balanced meals.” * 
Was that often, sometimes, or never true for (you/your household) in the last 12 months? 




Don't Know/refuse to answer 
 
27. In the last 12 months, since last March, did you and/or other persons in your 
household ever cut the size of your meals or skip meals because there wasn't enough 
money for food? * 
Mark only one oval. 
Yes Skip to question 28. 
No Skip to question 29. 
Don't know Skip to question 29. 
 
28. How often did this happen—almost every month, some months but not every month, 
or in only 1 or 2 months? 
Mark only one oval. 
Yes, almost every month 
Yes, some months but not every month 






29. In the last 12 months, did you ever eat less than you felt you should because there 
wasn't enough money for food? * 





30. In the last 12 months, were you ever hungry but didn't eat because there wasn't 
enough money for food? 









31. In the past 7 days, have you experienced any pain in your NECK? * 
Mark only one oval. 
Yes 
No After the last question in this section, skip to question 33. 
 
32. If yes, please indicate the intensity of your average NECK pain over the past 7 days 
on a scale of 0 (no pain) to 10 (worst pain imaginable). 
Mark only one oval. 
0 1 2 3 4 5 6 7 8 9 10 
 
About your Low Back Pain 
 




Mark only one oval. 
Yes 
No After the last question in this section, skip to "About your Alcohol and Drug 
use." 
 
34. If yes, please indicate the intensity of your average LOW BACK pain over the past 7 
days on a scale of 0 (no pain) to 10 (worst pain imaginable). 
Mark only one oval. 
0 1 2 3 4 5 6 7 8 9 10 
 
About your Alcohol and Drug use 
 
This is a brief survey about alcohol, tobacco products and other drugs. Some questions 
will be asked about your experience of using these substances across your lifetime and in 
the past three months. These substances can be smoked, swallowed, snorted, inhaled, 
injected or taken in the form of pills. Some of the substances listed may be prescribed by 
a doctor (like amphetamines, sedatives, pain medications). Please do not report 
MEDICATIONS AS PRESCRIBED by your doctor unless used outside the prescription 
(e.g. increased frequency or higher doses). While we are also interested in knowing about 
your use of various illicit drugs, please be assured that information on such use will be 
treated as strictly confidential. 
 
Tobacco use 
cigarettes, chewing tobacco, cigars, etc. 
 
35. In your life, have you ever used tobacco products (cigarettes, chewing tobacco, 
cigars, etc.)? (NON-MEDICAL USE ONLY) * 
Mark only one oval. 




cigarettes, chewing tobacco, cigars, etc. 
 
36. In the past 3 months, how often have you used tobacco products (cigarettes, chewing 
tobacco, cigars, etc.)? * 
Mark only one oval. 
Never Skip to question 39. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Tobacco use 





37. During the past three months, how often have you had a strong desire or urge to use 
tobacco products (cigarettes, chewing tobacco, cigars, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
38. During the past three months, how often has your use of tobacco products (cigarettes, 
chewing tobacco, cigars, etc.) led to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Tobacco use 
cigarettes, chewing tobacco, cigars, etc. 
 
39. Has a friend or relative or anyone else ever expressed concern about your use of 
tobacco products (cigarettes, chewing tobacco, cigars, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
40. Have you ever tried and failed to control, cut down or stop using tobacco products 
(cigarettes, chewing tobacco, cigars, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Alcohol use 
beer, wine, spirits, etc. 
 
41. In your life, have you ever used alcoholic beverages (beer, wine, spirits, etc.)? (NON-
MEDICAL USE ONLY) * 
Mark only one oval. 









42. In the past three months, how often have you used alcoholic beverages (beer, wine, 
spirits, etc.)? * 
Mark only one oval. 
Never Skip to question 46. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Alcohol use 
beer, wine, spirits, etc. 
 
43. During the past three months, how often have you had a strong desire or urge to use 
alcoholic beverages (beer, wine, spirits, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
44. During the past three months, how often has your use of alcoholic beverages (beer, 
wine, spirits, etc.) led to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
45. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of alcoholic beverages (beer, wine, spirits, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Alcohol use 
beer, wine, spirits, etc. 
 
46. Has a friend or relative or anyone else ever expressed concern about your use of 
alcoholic beverages (beer, wine, spirits, etc.)? 





Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
47. Have you ever tried and failed to control, cut down or stop using alcoholic beverages 
(beer, wine, spirits, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Cannabis use 
marijuana, pot, grass, hash, etc. 
 
48. In your life, have you ever used Cannabis (marijuana, pot, grass, hash, etc.)? (NON-
MEDICAL USE ONLY) * 
Mark only one oval. 




marijuana, pot, grass, hash, etc. 
 
49. In the past three months, how often have you used Cannabis (marijuana, pot, grass, 
hash, etc.)? * 
Mark only one oval. 
Never Skip to question 53. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Cannabis use 
marijuana, pot, grass, hash, etc 
. 
50. During the past three months, how often have you had a strong desire or urge to use 
Cannabis (marijuana, pot, grass, hash, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
51. During the past three months, how often has your use of Cannabis (marijuana, pot, 




Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
52. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Cannabis (marijuana, pot, grass, hash, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Cannabis use 
marijuana, pot, grass, hash, etc. 
 
53. Has a friend or relative or anyone else ever expressed concern about your use of 
Cannabis (marijuana, pot, grass, hash, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
54. Have you ever tried and failed to control, cut down or stop using Cannabis 
(marijuana, pot, grass, hash, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Cocaine use 
coke, crack, etc. 
55. In your life, have you ever used Cocaine (coke, crack, etc.)? (NON-MEDICAL USE 
ONLY) * 
Mark only one oval. 




coke, crack, etc. 
 
56. In the past three months, how often have you used Cocaine (coke, crack, etc.)? * 




Never Skip to question 60. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Cocaine use 
coke, crack, etc. 
 
57. During the past three months, how often have you had a strong desire or urge to use 
Cocaine (coke, crack, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
58. During the past three months, how often has your use of Cocaine (coke, crack, etc.) 
led to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
59. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Cocaine (coke, crack, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Cocaine use 
coke, crack, etc. 
 
60. Has a friend or relative or anyone else ever expressed concern about your use of 
Cocaine (coke, crack, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 





61. Have you ever tried and failed to control, cut down or stop using Cocaine (coke, 
crack, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Amphetamine type stimulant use 
speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc. 
 
62. In your life, have you ever used Amphetamine type stimulants (speed, diet pills, 
ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc.)? (NON-MEDICAL USE 
ONLY) * 
Mark only one oval. 
No Skip to question 69. 
Yes 
Amphetamine type stimulant use 
speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc. 
 
63. In the past three months, how often have you used Amphetamine type stimulants 
(speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc.)? * 
Mark only one oval. 
Never Skip to question 67. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Amphetamine type stimulant use 
speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc. 
 
64. During the past three months, how often have you had a strong desire or urge to use 
Amphetamine type stimulants (speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, 
uppers, amps, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
65. During the past three months, how often has your use of Amphetamine type 
stimulants (speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc.) 
led to health, social, legal or financial problems? 





Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
66. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Amphetamine type stimulants (speed, diet pills, 
ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Amphetamine type stimulant use 
speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc. 
 
67. Has a friend or relative or anyone else ever expressed concern about your use of 
Amphetamine type stimulants (speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, 
uppers, amps, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
68. Have you ever tried and failed to control, cut down or stop using Amphetamine type 
stimulants (speed, diet pills, ecstasy, Adderall, Dexedrine, bennies, uppers, amps, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Inhalant use 
nitrous, glue, gas, paint thinner, etc. 
 
69. In your life, have you ever used Inhalants (nitrous, glue, gas, paint thinner, etc.)? 
(NONMEDICAL USE ONLY) * 
Mark only one oval. 









70. In the past three months, how often have you used Inhalants (nitrous, glue, gas, paint 
thinner, etc.)? * 
Mark only one oval. 
Never Skip to question 74. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Inhalant use 
nitrous, glue, gas, paint thinner, etc. 
 
71. During the past three months, how often have you had a strong desire or urge to use 
Inhalants (nitrous, glue, gas, paint thinner, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
72. During the past three months, how often has your use of Inhalants (nitrous, glue, gas, 
paint thinner, etc.) led to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
73. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Inhalants (nitrous, glue, gas, paint thinner, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Inhalant use 
nitrous, glue, gas, paint thinner, etc. 
 
74. Has a friend or relative or anyone else ever expressed concern about your use of 
Inhalants (nitrous, glue, gas, paint thinner, etc.)? 





Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
75. Have you ever tried and failed to control, cut down or stop using Inhalants (nitrous, 
glue, gas, paint thinner, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Sedative or Sleeping Pill use 
Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc. 
 
76. In your life, have you ever used Sedatives or Sleeping Pills (Valium, Rohypnol, 
Ativan, Xanax, Clonazepam, etc.)? (NON-MEDICAL USE ONLY) * 
Mark only one oval. 
No Skip to question 83. 
Yes 
 
Sedative or Sleeping Pill use 
Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc. 
 
77. In the past three months, how often have you used Sedatives or Sleeping Pills 
(Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc.)? * 
Mark only one oval. 
Never Skip to question 81. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Sedative or Sleeping Pill use 
Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc. 
 
78. During the past three months, how often have you had a strong desire or urge to use 
Sedatives or Sleeping Pills (Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, 
tranks, blue heaven, yellow jackets, etc.)? 
Mark only one oval. 
Never 






Daily or Almost Daily 
 
79. During the past three months, how often has your use of Sedatives or Sleeping Pills 
(Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc.) led 
to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
80. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Sedatives or Sleeping Pills (Valium, Rohypnol, 
Ativan, Xanax, 
Clonazepam, downers, tranks, blue heaven, yellow jackets, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Sedative or Sleeping Pill use 
Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue heaven, yellow 
jackets, etc. 
 
81. Has a friend or relative or anyone else ever expressed concern about your use of 
Sedatives or Sleeping Pills (Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, 
tranks, blue heaven, yellow jackets, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
82. Have you ever tried and failed to control, cut down or stop using Sedatives or 
Sleeping Pills (Valium, Rohypnol, Ativan, Xanax, Clonazepam, downers, tranks, blue 
heaven, yellow jackets, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Hallucinogen use 





83. In your life, have you ever used Hallucinogens (LSD, acid, mushrooms, PCP, Special 
K, etc.)? 
(NON-MEDICAL USE ONLY) * 
Mark only one oval. 




LSD, acid, mushrooms, PCP, Special K, etc. 
 
84. In the past three months, how often have you used Hallucinogens (LSD, acid, 
mushrooms, PCP, Special K, etc.)? * 
Mark only one oval. 
Never Skip to question 88. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Hallucinogen use 
LSD, acid, mushrooms, PCP, Special K, etc. 
 
85. During the past three months, how often have you had a strong desire or urge to use 
Hallucinogens (LSD, acid, mushrooms, PCP, Special K, etc.)? 
Mark only one oval. 
Never 




Daily or Almost Daily 
86. During the past three months, how often has your use of Hallucinogens (LSD, acid, 
mushrooms, PCP, Special K, etc.) led to health, social, legal or financial problems? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
87. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Hallucinogens (LSD, acid, mushrooms, PCP, 
Special K, etc.)? 





Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Hallucinogen use 
LSD, acid, mushrooms, PCP, Special K, etc. 
 
88. Has a friend or relative or anyone else ever expressed concern about your use of 
Hallucinogens (LSD, acid, mushrooms, PCP, Special K, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
89. Have you ever tried and failed to control, cut down or stop using Hallucinogens 
(LSD, acid, mushrooms, PCP, Special K, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Opioid use 
heroin, morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc. 
 
90. In your life, have you ever used Opioids (heroin, morphine, methadone, codeine, 
Percocet, Fentanyl, Ts, cody, vike, etc.)? (NON-MEDICAL USE ONLY) * 
Mark only one oval. 




heroin, morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc. 
 
91. In the past three months, how often have you used Opioids (heroin, morphine, 
methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc.)? * 
Mark only one oval. 
Never Skip to question 95. 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Opioid use 





92. During the past three months, how often have you had a strong desire or urge to use 
Opioids (heroin, morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
93. During the past three months, how often has your use of Opioids (heroin, morphine, 
methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc.) led to health, social, legal or 
financial problems? 
Mark only one oval. 
Never 




Daily or Almost Daily 
94. During the past three months, how often have you failed to do what was normally 
expected of you because of your use of Opioids (heroin, morphine, methadone, codeine, 
Percocet, Fentanyl, Ts, cody, vike, etc.)? 
Mark only one oval. 
Never 
Once or Twice 
Monthly 
Weekly 
Daily or Almost Daily 
 
Opioid use 
heroin, morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc. 
 
95. Has a friend or relative or anyone else ever expressed concern about your use of 
Opioids 
(heroin, morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
96. Have you ever tried and failed to control, cut down or stop using Opioids (heroin, 
morphine, methadone, codeine, Percocet, Fentanyl, Ts, cody, vike, etc.)? 
Mark only one oval. 
No, Never 
Yes, in the past 3 months 







97. Have you ever used any drug by injection? (NON-MEDICAL USE ONLY) * 
Mark only one oval. 
No, never 
Yes, in the past 3 months 
Yes, but not in the past 3 months 
 
Student Life and Experience 
 
The following section will ask questions about how you feel about your universities 
policies and environment, and about your relationships with other people. 
 
98. I find university's learning environment conducive. * 
Conducive meaning: favourable, beneficial, advantageous, encouraging etc 





99. I find academic policies of my university student-friendly. * 





100. I have no close relationships that make me feel good. * 






101. There is no one I feel comfortable talking about my problems with. * 














Mark only one oval. 





103. Number of Dependents * 
Dependent is a person who relies on another person for support (especially financial 
support) 
Mark only one oval. 






6 or more 
 
104. What was your academic average in your last year? * 
If you are in 1st year, then report the average for your last year of high school. If you are 
in 2nd year, then report the average for your 1st year. 
Mark only one oval. 
below 60 
between 60 to 65 
between 66 to 69 
between 70 to 75 
between 76 to 79 
between 80 to 85 
between 86 to 89 
between 90 to 95 
between 95 to 100 
 
105. What is your annual personal income? 
Mark only one oval. 
$0 - $4,999 
$5,000 - $9,999 
$10,000 - $19,999 
Above $20,000 
 
106. What is your households' annual combined personal income? 
Mark only one oval. 
$0 - $49,999 
$50,000 - $59,999 






107. How many hours a week do you work for pay? * 
During the academic calendar year (i.e. September - April) 
Mark only one oval. 
0 
1 - 9 hours 
10 - 19 hours 
20 - 29 hours 
30 - 39 hours 
more than 40 hours 
 
108. What is your current household living arrangement? * 
During the academic calendar year (i.e. September - April) 
Check all that apply. 
Living with relatives 
Living with non-relatives (roommates/housemates) 
Living in a student residence 
Living alone 
Living with a partner 
 
109. On average how long is your commute time to the University? * 
Mark only one oval. 
Less than 15 minutes 
15 to 29 minutes 
30 to 44 minutes 
45 minutes or more 
 
110. Were you born in Canada? * 
Mark only one oval. 
Yes Skip to question 111. 
No 
 
111. Please check if you are registered at the University as: * 
Mark only one oval. 
An International student 
A Domestic student 
 
112. What were the ethnic or cultural origins of your ancestors? * 
An ancestor is usually more distant than a grandparent. 















113. What is your parents marital status? * 
Mark only one oval. 






114. What is the employment status of your primary guardian? *Please check all that 
apply * 










I Don't know 
 
115. What is the employment status of your secondary guardian? *Please check all that 
apply * 
















































Determine Crude Associations:  




Run Bivariate Models:  
(1) Sedative Use + Depression + Covariates  
(2) Sedative Use + Anxiety + Covariates (3) Sedative Use + Stress + Covariates 
 
*covariates entered individually, one at a time 
 
 Compare Beta coefficients between crude models and bivariate models. Remove any 
covariates that do not change the beta coefficient by +/- 10%   
 
Run Regression Models:  
(1) Sedative Use + Depression + Covariates  
(2) Sedative Use + Anxiety + Covariates (3) Sedative Use + Stress + Covariates 
 
*all covariates that made the +/- 10% cut off criteria were entered in at once 
 
 Remove any covariates that had a p>0.05 one at a time. Remove any covariates that 
did not change the Beta coefficient by +/- 10%. Keep any covariates with a p<0.05 or 
whose removal resulted in a +/- 10% change in Beta 
  
 
Final Regression Models 
(1) Sedative Use + Depression + Covariates  
(2) Sedative Use + Anxiety + Covariates (3) Sedative Use + Stress + Covariates 
 
*all covariates met the criteria of changing the Beta coefficient from the initial crude 
models by +/- 10%, had a p<0.05 in the final model, or a p>0.05 but resulted in a more 
than +/- 10% change in Beta once removed from the final model 
